{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":101,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":101,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"5f0ee675a940","filters":{"venue":"Clinical Drug Investigation"}},"results":[{"id":"W307221476","doi":"10.2165/00044011-200424030-00004","title":"Depression during Pregnancy","year":2004,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":313,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Pregnancy; Depression (economics); Epidemiology; Observational study; Psychiatry; Dosing; Antidepressant; Pharmacotherapy; Intensive care medicine; Anxiety; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.05335177734112267,"gpt":0.3646548667146848,"spread":0.3113030893735622,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001753955,0.0001096385,0.0002057354,0.00004333161,0.0001188929,0.00001097189,0.00006476387,0.0001058652,0.00005142733],"category_scores_gemma":[0.0002197985,0.00009262739,0.00008782576,0.00009358195,0.0001185496,0.0001264309,0.00004217487,0.0003017362,0.0002244581],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006292539,"about_ca_system_score_gemma":0.00009706862,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000331907,"about_ca_topic_score_gemma":0.000004336129,"domain_scores_codex":[0.9986877,0.00006950066,0.0005524109,0.000280347,0.0002010092,0.0002090115],"domain_scores_gemma":[0.9991483,0.00006383252,0.0001339674,0.0002563647,0.00004148363,0.0003560612],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003092907,0.0002716368,0.9905277,0.003094695,0.00002206821,0.0001489758,0.0004772503,0.00003115347,0.001154771,0.0009538438,0.00006026416,0.00294834],"study_design_scores_gemma":[0.002634909,0.0001239512,0.9206294,0.0158928,0.00002781977,0.00007920502,0.00001388199,0.00002186295,0.05497203,0.005354794,0.0001325288,0.0001167753],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941307,0.000685551,0.00003636633,0.002471071,0.0005842173,0.000406469,0.000002312052,0.000135916,0.001547456],"genre_scores_gemma":[0.995946,0.0002563872,0.001347933,0.0007798421,0.0002651306,0.0000327571,0.00002245306,0.00001746123,0.001332007],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06989827,"threshold_uncertainty_score":0.3777235,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2003069609","doi":"10.2165/11533440-000000000-00000","title":"Efficacy and Safety of Tapentadol Extended Release Compared with Oxycodone Controlled Release for the Management of Moderate to Severe Chronic Pain Related to Osteoarthritis of the Knee","year":2010,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":227,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Tapentadol; Medicine; Oxycodone; Placebo; Anesthesia; Osteoarthritis; Discontinuation; Analgesic; Tramadol; Chronic pain; Opioid; Internal medicine; Physical therapy","retraction":null,"screen_n_in":null,"score":{"opus":0.01585256211730917,"gpt":0.2915583671300399,"spread":0.2757058050127307,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001224465,0.0001776376,0.0006500198,0.00005023172,0.00009046106,0.00000760765,0.0001384736,0.00008428997,0.00001875798],"category_scores_gemma":[0.0009000384,0.0001029302,0.0001492295,0.0002716835,0.0003667194,0.0000382615,0.00008016872,0.0002120647,0.000002374696],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003773423,"about_ca_system_score_gemma":0.0001865039,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000440287,"about_ca_topic_score_gemma":0.0001095189,"domain_scores_codex":[0.9978399,0.0002910813,0.00106345,0.0003276813,0.000303911,0.0001739236],"domain_scores_gemma":[0.9971886,0.001268311,0.0004276643,0.0006544381,0.0002434189,0.0002175657],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.2526701,0.008655268,0.09181137,0.007033513,0.008477314,0.00004373423,0.01690164,0.02743585,0.0451351,0.0215167,0.00489685,0.5154225],"study_design_scores_gemma":[0.1530001,0.006589833,0.7916675,0.004024687,0.002756523,0.00001026216,0.001593835,0.02865211,0.008482239,0.002266366,0.0005491384,0.0004074708],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.985087,0.0002090927,0.0003343899,0.006897829,0.0001219674,0.007212207,0.00004295272,0.00001999741,0.00007456417],"genre_scores_gemma":[0.9958641,0.0000716146,0.002862107,0.000544325,0.00002535883,0.0002893039,0.00004646584,0.00002560224,0.0002711197],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6998561,"threshold_uncertainty_score":0.419737,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W127233696","doi":"10.2165/00044011-200020050-00005","title":"Efficacy and Safety of Inhaled Zanamivir for the Treatment of Influenza in Patients with Asthma or Chronic Obstructive Pulmonary Disease","year":2000,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Inhalation and Respiratory Drug Delivery","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Cegep de Saint Jerome","funders":"","keywords":"Medicine; Zanamivir; Asthma; Placebo; COPD; Exacerbation; Internal medicine; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.03052877370913406,"gpt":0.3122925710824548,"spread":0.2817637973733207,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001956482,0.0001119777,0.000290256,0.00005331834,0.00004866856,0.000003139063,0.00003986711,0.00006239365,0.00004961855],"category_scores_gemma":[0.0002183247,0.00006051903,0.00006713433,0.0001621981,0.0004988523,0.00007050637,0.000006822834,0.00007956433,0.000002192542],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007162483,"about_ca_system_score_gemma":0.0002442495,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001332373,"about_ca_topic_score_gemma":0.00001561059,"domain_scores_codex":[0.9988022,0.000114108,0.0006213837,0.0002027854,0.0001580148,0.0001015083],"domain_scores_gemma":[0.9986443,0.00070701,0.0001917886,0.0002076415,0.0001205779,0.0001286776],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01806388,0.001304293,0.763302,0.0001956041,0.0001099504,0.000008922493,0.0007184367,0.0008674279,0.00001935433,0.00009929219,0.00002342994,0.2152874],"study_design_scores_gemma":[0.009289803,0.001192446,0.984975,0.0001882936,0.0001146656,7.366449e-7,0.0000408796,0.002431291,0.0001307358,0.00004274076,0.001524894,0.00006846873],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9979206,0.0002605191,0.000008162076,0.0002401762,0.00004141655,0.001430808,0.00003147379,0.000009374303,0.00005744515],"genre_scores_gemma":[0.9990609,0.0001445715,0.0001335639,0.0002503255,0.00007222577,0.00004011609,0.00005604504,0.00001192648,0.0002303063],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.221673,"threshold_uncertainty_score":0.2467895,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2161313492","doi":"10.1007/s40261-014-0266-2","title":"Comparative Changes of Lipid Levels in Treatment-Naive, HIV-1-Infected Adults Treated with Dolutegravir vs. Efavirenz, Raltegravir, and Ritonavir-Boosted Darunavir-Based Regimens Over 48 Weeks","year":2015,"lang":"en","type":"review","venue":"Clinical Drug Investigation","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"GlaxoSmithKline (Canada)","funders":"ViiV Healthcare; GlaxoSmithKline","keywords":"Darunavir; Dolutegravir; Raltegravir; Efavirenz; Medicine; Ritonavir; Integrase inhibitor; Pharmacology; Pharmacotherapy; Human immunodeficiency virus (HIV); Virology; Antiretroviral therapy; Internal medicine; Viral load","retraction":null,"screen_n_in":null,"score":{"opus":0.1577327112019011,"gpt":0.4296276152708972,"spread":0.2718949040689961,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000686128,0.001020141,0.004645805,0.000678651,0.000146311,0.00003167001,0.0001953902,0.0009363844,0.00003940495],"category_scores_gemma":[0.0002117028,0.0007103451,0.000347024,0.001396211,0.0009487779,0.0001369548,0.00005316069,0.001049072,0.0001071352],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007446793,"about_ca_system_score_gemma":0.001926049,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001277282,"about_ca_topic_score_gemma":0.0005595307,"domain_scores_codex":[0.9940063,0.00137805,0.002269332,0.001289648,0.00050372,0.0005528939],"domain_scores_gemma":[0.9945658,0.001266482,0.001744477,0.001003216,0.000529293,0.0008907688],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.004359283,0.008747147,0.1646861,0.02031817,0.003388024,0.0002718444,0.003576536,0.00001745814,0.00001617052,0.0003881741,0.008682732,0.7855484],"study_design_scores_gemma":[0.0569577,0.01336473,0.1611243,0.1341148,0.01174984,0.0001419327,0.0002677881,0.002225527,0.000114397,0.0002155598,0.6172447,0.002478682],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.2863205,0.698056,0.00001240072,0.001139716,0.0002560271,0.01077596,0.002191823,0.0003042349,0.0009433486],"genre_scores_gemma":[0.03422627,0.9395304,0.002533888,0.0003810923,0.0003942994,0.001687657,0.01871694,0.0002652997,0.002264092],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7830697,"threshold_uncertainty_score":0.9995348,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1070976522","doi":"10.2165/0044011-200828120-00002","title":"Metabolism, Distribution and Elimination of Lisdexamfetamine Dimesylate","year":2008,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Center for Diagnosis and Research on Alzheimer's Disease","funders":"","keywords":"Tolerability; Pharmacokinetics; Urine; Medicine; Pharmacology; Adverse effect; Volume of distribution; Whole blood; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.09007126275613525,"gpt":0.3601962226793686,"spread":0.2701249599232333,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005304575,0.0001083742,0.0003445782,0.00006009089,0.00007589055,0.000005161139,0.00003543178,0.0001143052,0.00002895087],"category_scores_gemma":[0.001953448,0.00009939117,0.00009987487,0.0002326745,0.0005085832,0.0002218192,0.00003264729,0.000216731,0.00002305229],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001800466,"about_ca_system_score_gemma":0.00007781055,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002282561,"about_ca_topic_score_gemma":0.000002692411,"domain_scores_codex":[0.9986137,0.0001545117,0.0006117869,0.0002505506,0.0002565493,0.0001129056],"domain_scores_gemma":[0.9988259,0.0002941221,0.0002658342,0.0002002301,0.0002633059,0.0001505895],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000249254,0.0007606977,0.9594856,0.0002161035,0.0001388551,0.00001542611,0.0007595941,0.00004145876,0.009011418,0.005984854,0.002540447,0.0207963],"study_design_scores_gemma":[0.001366402,0.00008501141,0.9918142,0.00005014211,0.0001444996,0.00003368659,0.0001197849,0.002474397,0.001944485,0.0003708681,0.001503527,0.0000929819],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947229,0.0002566593,0.001137381,0.003182772,0.0001465777,0.0002773135,0.00001611027,0.0000528426,0.0002074339],"genre_scores_gemma":[0.9975014,0.0004022825,0.0007464053,0.0002618252,0.0001107539,0.000009475362,0.0003733388,0.0000131169,0.0005813972],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03232863,"threshold_uncertainty_score":0.4053054,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2078098902","doi":"10.2165/00044011-200020020-00005","title":"Mammographic Density in Postmenopausal Women Treated with Tibolone, Estriol or Conventional Hormone Replacement Therapy","year":2000,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Cegep de Trois-Rivieres; Cegep de Thetford","funders":"","keywords":"Tibolone; Medicine; Estriol; Medroxyprogesterone acetate; Hormone replacement therapy (female-to-male); Menopause; Estrogen; Medroxyprogesterone; Internal medicine; Gynecology; Urology; Testosterone (patch)","retraction":null,"screen_n_in":null,"score":{"opus":0.02794496057376424,"gpt":0.2974984960247114,"spread":0.2695535354509472,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007097976,0.0001951858,0.0003796031,0.0001986743,0.0000625257,0.00003830727,0.00007743265,0.00009705761,0.0002937136],"category_scores_gemma":[0.00008282706,0.0001375604,0.00009072274,0.0008035944,0.0004927802,0.0002313568,0.00001093278,0.0003102906,0.00004085701],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006605902,"about_ca_system_score_gemma":0.0001846714,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000906577,"about_ca_topic_score_gemma":0.00001960704,"domain_scores_codex":[0.9981459,0.0001564504,0.0006361009,0.0004308699,0.0003169399,0.0003137211],"domain_scores_gemma":[0.9990057,0.0001849505,0.0001261291,0.0002651903,0.0000856996,0.0003322844],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00984894,0.000795037,0.9419928,0.00001826395,0.0001411949,0.0001106398,0.0001542902,0.000005945992,0.0001991495,0.00009738601,0.0007222705,0.04591407],"study_design_scores_gemma":[0.008821465,0.003103195,0.9842681,0.000169359,0.00003993861,0.0001139695,0.00008483116,0.000172015,0.0003176988,0.000947654,0.001766804,0.0001949845],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966715,0.0001278969,0.000006621547,0.001376395,0.00003423853,0.0006069727,0.00001127062,0.00009960141,0.001065515],"genre_scores_gemma":[0.9956697,0.0003562884,0.0004946245,0.001730097,0.00009492932,0.00009922653,0.0002106939,0.00002099978,0.001323447],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04571908,"threshold_uncertainty_score":0.5609552,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2765390494","doi":"10.1007/s40261-017-0581-5","title":"Impact of Herpes Zoster and Post-Herpetic Neuralgia on Health-Related Quality of Life in Japanese Adults Aged 60 Years or Older: Results from a Prospective, Observational Cohort Study","year":2017,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"GlaxoSmithKline","keywords":"Medicine; Quality of life (healthcare); Rash; Cohort; Observational study; Postherpetic neuralgia; Prospective cohort study; Neuralgia; Cohort study; Physical therapy; Brief Pain Inventory; McGill Pain Questionnaire; Pediatrics; Internal medicine; Neuropathic pain; Chronic pain; Anesthesia; Visual analogue scale","retraction":null,"screen_n_in":null,"score":{"opus":0.1218845237545927,"gpt":0.4224204255638445,"spread":0.3005359018092518,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001555366,0.0001656657,0.0007647356,0.00008928061,0.00009908281,0.00002054213,0.00008706434,0.0001357238,0.00003507323],"category_scores_gemma":[0.007622916,0.0001231157,0.000127146,0.0001450215,0.0003460736,0.0001614531,0.00004713333,0.0002757487,0.000007937254],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001028699,"about_ca_system_score_gemma":0.0003838962,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0381384,"about_ca_topic_score_gemma":0.003218566,"domain_scores_codex":[0.9967758,0.0006108221,0.001693351,0.0004566144,0.0003148037,0.0001485863],"domain_scores_gemma":[0.9968141,0.001065259,0.001080785,0.0005804806,0.0002127383,0.0002466329],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003820162,0.001876159,0.9865546,0.00004429277,0.000240937,0.00001406404,0.003225029,0.00001039181,0.00002305221,0.000004819027,0.00006985127,0.004116673],"study_design_scores_gemma":[0.01311986,0.00188289,0.9837182,0.0005010841,0.00005877147,8.836693e-7,0.000240681,0.0002032586,0.00001173965,0.0001679521,0.000001304964,0.00009340801],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968054,0.00002507671,1.737525e-7,0.001027629,0.0001162216,0.001777144,0.0001681529,0.00002233607,0.0000578531],"genre_scores_gemma":[0.9992769,0.00002877864,0.0001090169,0.0001891488,0.00003849054,0.00004151551,0.0001839683,0.00001649977,0.0001156292],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03491983,"threshold_uncertainty_score":0.9682667,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2327894690","doi":"10.1007/s40261-016-0397-8","title":"Benzodiazepine Use, Misuse, and Harm at the Population Level in Canada: A Comprehensive Narrative Review of Data and Developments Since 1995","year":2016,"lang":"en","type":"review","venue":"Clinical Drug Investigation","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Toronto; Simon Fraser University; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Harm; Benzodiazepine; Narrative review; Psychiatry; Pharmacotherapy; Population; Intensive care medicine; Psychology; Environmental health; Internal medicine; Social psychology","retraction":null,"screen_n_in":null,"score":{"opus":0.3780999626373712,"gpt":0.4652990289311206,"spread":0.0871990662937494,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008431658,0.0002847593,0.001494587,0.00007657475,0.0000828366,0.00001272739,0.0001853484,0.0001195321,0.00001631537],"category_scores_gemma":[0.002923414,0.0001576109,0.00006862853,0.0002621725,0.0003289102,0.0001631989,0.0004012543,0.0003715121,0.000004544052],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005606179,"about_ca_system_score_gemma":0.003824119,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.08075766,"about_ca_topic_score_gemma":0.3460718,"domain_scores_codex":[0.9966394,0.0007581125,0.001372104,0.0006003047,0.0004267684,0.0002033054],"domain_scores_gemma":[0.9957107,0.002534607,0.0006552681,0.0006225249,0.0001844738,0.0002924721],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001574232,0.00004523962,0.03056575,0.03731052,0.000329797,0.00003252318,0.00006854411,2.314097e-8,3.527306e-7,0.00006415079,0.007347596,0.924078],"study_design_scores_gemma":[0.002420992,0.00008822228,0.335456,0.2673495,0.0007075329,0.00005923245,0.00003358355,0.0000252548,0.000002505615,0.0001317134,0.3934159,0.0003095743],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01448016,0.9797777,0.000001621517,0.002970404,0.00007393658,0.002025312,0.0006598989,0.000005425105,0.000005557942],"genre_scores_gemma":[0.000297212,0.9934555,0.001546541,0.0006552579,0.00005660081,0.00007408826,0.003731048,0.00002084928,0.0001628939],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9237685,"threshold_uncertainty_score":0.9253637,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2179646396","doi":"10.1007/s40261-015-0336-0","title":"Guanfacine Extended Release: A New Pharmacological Treatment Option in Europe","year":2015,"lang":"en","type":"review","venue":"Clinical Drug Investigation","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Guanfacine; Atomoxetine; Medicine; Stimulant; Methylphenidate; Dopamine; Context (archaeology); Attention deficit hyperactivity disorder; Monoaminergic; Pharmacology; Norepinephrine; Pharmacotherapy; Neuroscience; Psychiatry; Psychology; Clonidine; Receptor; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.3967785501146209,"gpt":0.5193796967377047,"spread":0.1226011466230837,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001204932,0.0005668399,0.002616347,0.0002935066,0.00004480053,0.00003374683,0.0001567385,0.0006098022,0.0002592416],"category_scores_gemma":[0.003032136,0.0004211022,0.0005629668,0.001093668,0.0002282794,0.0001763604,0.00008291749,0.001124293,0.001392967],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005848858,"about_ca_system_score_gemma":0.002502029,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006666887,"about_ca_topic_score_gemma":0.00001901505,"domain_scores_codex":[0.994873,0.001367536,0.00199086,0.0009493597,0.0004695442,0.0003496718],"domain_scores_gemma":[0.9970307,0.0006272718,0.0007488385,0.0005107442,0.0002849862,0.0007974851],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008699005,0.0009388346,0.0005416139,0.001131584,0.0001771117,0.0001467227,0.00005153607,0.000008255255,0.000003242794,0.0001162501,0.006291753,0.9905061],"study_design_scores_gemma":[0.003730834,0.0005946398,0.001380649,0.004276047,0.00253863,0.00009048189,0.00003162643,0.0003009451,8.660273e-7,0.0002163845,0.9864545,0.0003843352],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01095868,0.982786,0.00005375544,0.001881602,0.0006198225,0.002793163,0.00002252941,0.0002021164,0.0006823367],"genre_scores_gemma":[0.0002418766,0.9877103,0.0008460813,0.0004744248,0.0008472989,0.0001640232,0.001319707,0.00008518282,0.008311081],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9901218,"threshold_uncertainty_score":0.9998241,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2747687728","doi":"10.2165/11530800-000000000-00000","title":"Subjective Effects and Safety of Whole and Tampered Morphine Sulfate and Naltrexone Hydrochloride (ALO-01) Extended-Release Capsules versus Morphine Solution and Placebo in Experienced Non-Dependent Opioid Users","year":2009,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"Johnson and Johnson","keywords":"Morphine; Placebo; Euphoriant; Medicine; Anesthesia; Visual analogue scale; Opioid; Oxycodone; Naltrexone; Crossover study; Heroin; Pharmacology; Internal medicine; Drug; Psychiatry","retraction":null,"screen_n_in":null,"score":{"opus":0.01725757387396902,"gpt":0.2982667005313795,"spread":0.2810091266574105,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006136888,0.0003013383,0.0006503894,0.0001674679,0.0001070717,0.00002434122,0.00005009534,0.0001768783,0.000003187677],"category_scores_gemma":[0.001148324,0.0002736467,0.00004697414,0.0002079707,0.0006460525,0.0002788259,0.00007215545,0.0003019666,0.000002742913],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009545726,"about_ca_system_score_gemma":0.0001157542,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000469055,"about_ca_topic_score_gemma":0.0001688388,"domain_scores_codex":[0.9978667,0.0001775639,0.0007379075,0.0006608165,0.0002801176,0.000276864],"domain_scores_gemma":[0.9983601,0.0006410379,0.0002529919,0.0002528212,0.00007913587,0.0004139361],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02591002,0.001938859,0.6419762,0.001367862,0.0004006067,0.0002246241,0.02423229,0.0001501039,0.2688015,0.0004536927,0.0002001016,0.03434413],"study_design_scores_gemma":[0.02114099,0.0015546,0.9464189,0.0004865662,0.0001931773,0.0000180173,0.001140519,0.006548349,0.02098563,0.001262059,0.000007370168,0.0002437608],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9952263,0.001338541,0.0000509043,0.001896255,0.0001399324,0.001251978,0.00002764132,0.00003670103,0.00003180643],"genre_scores_gemma":[0.9964765,0.001994221,0.001039107,0.0002093719,0.00006463798,0.00005349044,0.0001099215,0.00002086338,0.00003182764],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3044428,"threshold_uncertainty_score":0.9999716,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2460337359","doi":"10.1007/s40261-016-0437-4","title":"Vedolizumab Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability Following Administration of a Single, Ascending, Intravenous Dose to Healthy Volunteers","year":2016,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"Takeda Pharmaceuticals U.S.A.","keywords":"Vedolizumab; Medicine; Pharmacokinetics; Tolerability; Pharmacodynamics; Adverse effect; Placebo; Ulcerative colitis; Pharmacology; Area under the curve; Internal medicine; Gastroenterology; Cmax; Disease; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.02330174514583199,"gpt":0.3287272009553941,"spread":0.3054254558095622,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009591628,0.0001807242,0.0002513044,0.00005281137,0.00007636988,0.00001739362,0.0001574176,0.0001349743,0.0000162029],"category_scores_gemma":[0.001247676,0.0001626055,0.0001360094,0.00008235212,0.0003062976,0.00001721448,0.0001039648,0.00009952225,0.000009546298],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006150078,"about_ca_system_score_gemma":0.0002561258,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001201635,"about_ca_topic_score_gemma":0.00006534055,"domain_scores_codex":[0.9978089,0.0003321916,0.0009123597,0.0005110762,0.0001881968,0.0002472522],"domain_scores_gemma":[0.9987776,0.0001011513,0.0002329336,0.0003124058,0.0001384116,0.0004375388],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.006879058,0.0006318055,0.1792902,0.0002686296,0.0002089058,0.00003999029,0.000371984,0.0001278968,0.7600069,0.0004693294,0.001716233,0.04998909],"study_design_scores_gemma":[0.008856723,0.002277012,0.8409926,0.0003420729,0.0002653229,0.00001543927,0.0001021474,0.001713803,0.1345896,0.001138928,0.008766754,0.0009396567],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954826,0.00006335985,0.001634388,0.001549546,0.0005688406,0.0005078926,0.00006690813,0.00002578499,0.0001006361],"genre_scores_gemma":[0.997517,0.0001090525,0.0009491808,0.0009085242,0.0002946583,0.00001599947,0.00007689436,0.00002544766,0.0001032412],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6617024,"threshold_uncertainty_score":0.6630861,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2771385809","doi":"10.1007/s40261-017-0610-4","title":"Pharmacokinetics of Oral and Intravenous Paracetamol (Acetaminophen) When Co-Administered with Intravenous Morphine in Healthy Adult Subjects","year":2017,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Institute of Environmental Health Sciences; Mallinckrodt Pharmaceuticals","keywords":"Pharmacokinetics; Medicine; Acetaminophen; Morphine; Dosing; Pharmacology; Bioavailability; Oral administration; Opioid; Anesthesia; Analgesic; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.06099708031379279,"gpt":0.3626744945745505,"spread":0.3016774142607577,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001074084,0.0002159279,0.0006354176,0.0001244712,0.00012444,0.00005073614,0.0002092995,0.0001290644,0.00002345406],"category_scores_gemma":[0.001086993,0.0001816953,0.00005620442,0.00008615504,0.0009092647,0.0001699123,0.00007574031,0.0004252347,0.00001192618],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003876128,"about_ca_system_score_gemma":0.0001718798,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003835379,"about_ca_topic_score_gemma":0.0002810706,"domain_scores_codex":[0.9979292,0.0001910783,0.00085375,0.0004256987,0.0003041048,0.0002961744],"domain_scores_gemma":[0.998099,0.0002270855,0.0005912484,0.0005921182,0.0001525577,0.0003380491],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002141159,0.0005004382,0.97174,0.0006130314,0.00009743596,0.0001192039,0.001406466,0.000008860086,0.0005510368,0.0005204304,0.000932444,0.02136951],"study_design_scores_gemma":[0.00871125,0.001969464,0.9806345,0.0003995727,0.0001990738,0.000008008963,0.0001314552,0.003951917,0.001677791,0.001558815,0.0005426524,0.000215561],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.990752,0.00009550983,0.00009489321,0.007346652,0.0001643643,0.0009121393,0.000009199892,0.00003597893,0.0005892748],"genre_scores_gemma":[0.9919904,0.00046431,0.004624036,0.002345002,0.0001389998,0.00002411862,0.00007077979,0.00002850591,0.0003137827],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02115395,"threshold_uncertainty_score":0.7409321,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2150339979","doi":"10.2165/11595370-000000000-00000","title":"Potential New Approaches to Modifying Intestinal GLP-1 Secretion in Patients with Type 2 Diabetes Mellitus","year":2011,"lang":"en","type":"review","venue":"Clinical Drug Investigation","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Daiichi Sankyo Europe; Daiichi-Sankyo; McGill University","keywords":"Medicine; Type 2 Diabetes Mellitus; Pharmacotherapy; Diabetes mellitus; Secretion; Internal medicine; Type 2 diabetes; Gastroenterology; Pharmacology; Intensive care medicine; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.2086526985467771,"gpt":0.3294358003476996,"spread":0.1207831018009225,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006008581,0.0004473092,0.001424907,0.0003296579,0.00004105998,0.00004323349,0.0001773278,0.0002647122,0.00004273052],"category_scores_gemma":[0.0004187662,0.0003278908,0.000242617,0.000591926,0.0001357042,0.0001413883,0.0001285944,0.00050679,0.0002421878],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001857828,"about_ca_system_score_gemma":0.0003389219,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003726857,"about_ca_topic_score_gemma":0.00001167403,"domain_scores_codex":[0.9972404,0.0002579979,0.001091992,0.0007261922,0.0003121562,0.0003713099],"domain_scores_gemma":[0.9983826,0.0001588099,0.0004334006,0.0004494887,0.00007338245,0.0005022886],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008339657,0.0003692894,0.03610646,0.003868436,0.0002491681,0.000004981167,0.00009518626,0.000005812239,3.102084e-8,0.0003418414,0.0009605674,0.9579148],"study_design_scores_gemma":[0.007969528,0.005568857,0.1380519,0.0779773,0.01102597,0.000002129648,0.00004116201,0.0005397152,0.000006541132,0.003078779,0.7537782,0.001959861],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.07622526,0.9146059,0.0001781821,0.0003854468,0.0009907542,0.006200132,0.00001233848,0.0002054931,0.001196464],"genre_scores_gemma":[0.005474056,0.9708376,0.01475011,0.0007083677,0.0009627471,0.0003231421,0.004946135,0.000198259,0.001799566],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.955955,"threshold_uncertainty_score":0.9999173,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2771762421","doi":"10.1007/s40261-017-0598-9","title":"Lithium Toxicity in Older Adults: a Systematic Review of Case Reports","year":2017,"lang":"en","type":"review","venue":"Clinical Drug Investigation","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"China Scholarship Council","keywords":"Medicine; Polypharmacy; Lithium (medication); Toxicity; Internal medicine; Comorbidity","retraction":null,"screen_n_in":null,"score":{"opus":0.1163607201254347,"gpt":0.4331381137862295,"spread":0.3167773936607948,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003352085,0.0003886604,0.005206232,0.0001406041,0.00005007265,0.00001475,0.0001145888,0.0004434715,0.00002783041],"category_scores_gemma":[0.008994935,0.000264507,0.001058253,0.0002226036,0.0002557874,0.00008024042,0.00007660636,0.0006861273,0.00003639463],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001254784,"about_ca_system_score_gemma":0.0007503435,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001656713,"about_ca_topic_score_gemma":0.0001452734,"domain_scores_codex":[0.9934607,0.0009615467,0.004427338,0.000618474,0.0003374338,0.0001945122],"domain_scores_gemma":[0.9939919,0.0006457916,0.003245736,0.00163869,0.0002022287,0.0002756994],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.000003024694,0.0003066341,0.0005816608,0.9479422,0.0001938688,0.001778458,0.00006820977,3.111959e-9,3.128737e-9,0.00001240431,0.0003229267,0.04879063],"study_design_scores_gemma":[0.0004576679,0.00008187249,0.000252842,0.9686702,0.006980577,0.005444266,0.00001370103,0.000003457188,4.249972e-7,0.00006383624,0.01783921,0.0001919715],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001332383,0.9923468,0.000002273252,0.0002092533,0.0002890342,0.00659092,0.00002575134,0.00003085874,0.0003719307],"genre_scores_gemma":[0.0002028223,0.9979218,0.0001844708,0.000265381,0.0001033567,0.000537246,0.0003649929,0.000041038,0.0003789096],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.04859866,"threshold_uncertainty_score":0.9999807,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2789269735","doi":"10.1007/s40261-018-0626-4","title":"Antipsychotic Prescribing and Safety Monitoring Practices in Children and Youth: A Population-Based Study in Alberta, Canada","year":2018,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Pharmacotherapy; Antipsychotic; Population; Psychiatry; Family medicine; Environmental health; Schizophrenia (object-oriented programming)","retraction":null,"screen_n_in":null,"score":{"opus":0.07601212069905343,"gpt":0.376873753978564,"spread":0.3008616332795105,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007216058,0.0001027559,0.0002207474,0.00009877339,0.00006864566,0.00002788071,0.00003934549,0.00004891981,0.000003553258],"category_scores_gemma":[0.002718028,0.0000887344,0.00001414509,0.0002039486,0.00008239791,0.0001245587,0.00002474211,0.0002463767,0.000001295375],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000108407,"about_ca_system_score_gemma":0.0004278765,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.7586482,"about_ca_topic_score_gemma":0.8585592,"domain_scores_codex":[0.9985188,0.0002765374,0.0004571281,0.0003458167,0.0002318289,0.000169856],"domain_scores_gemma":[0.9986873,0.0007190396,0.0001563961,0.0001699428,0.00004561689,0.0002217139],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0009264816,0.0001721347,0.9960549,0.000009650545,0.0000252654,0.000006297037,0.0004616481,0.000005061517,0.000002882437,0.00001844708,0.000006022266,0.002311197],"study_design_scores_gemma":[0.005206821,0.0002553033,0.9927219,0.0002006959,0.00004425161,0.000002200594,0.0003030444,0.0009378486,0.00003531126,0.000217931,7.387577e-7,0.00007395369],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9973391,0.00008166691,6.076663e-7,0.001600996,0.00009451587,0.000850976,0.000004727466,0.000008987115,0.0000183928],"genre_scores_gemma":[0.9991461,0.00001865818,0.0005087692,0.00009993094,0.000133504,0.0000139172,0.00005247275,0.000009724295,0.00001693381],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09991098,"threshold_uncertainty_score":0.3618484,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2074097337","doi":"10.1007/s40261-013-0110-0","title":"Evaluation of the Single-dose Pharmacokinetics of Bilastine in Subjects with Various Degrees of Renal Insufficiency","year":2013,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"inVentiv Health Clinical","funders":"","keywords":"Medicine; Pharmacokinetics; Renal function; Antihistamine; Urology; Internal medicine; Pharmacology","retraction":null,"screen_n_in":null,"score":{"opus":0.08899851646535378,"gpt":0.329584416136197,"spread":0.2405858996708432,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00157,0.00008782389,0.0002858778,0.00009058737,0.00001770736,0.000003407701,0.00007522752,0.00007409372,0.00004269841],"category_scores_gemma":[0.002404065,0.00005593986,0.00005630296,0.00048706,0.0004677436,0.00007429251,0.00002620926,0.0001570903,0.000001624761],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004179548,"about_ca_system_score_gemma":0.0004071505,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000203574,"about_ca_topic_score_gemma":0.0001192767,"domain_scores_codex":[0.9976823,0.0004210004,0.0009156577,0.0001618177,0.0007270655,0.0000921355],"domain_scores_gemma":[0.9975804,0.0003188266,0.0005993824,0.0002159377,0.001224462,0.00006097675],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004806224,0.003725939,0.6159947,0.000425497,0.0001730427,0.000003852556,0.004814918,0.05474835,0.2548953,0.001116904,0.0006758178,0.06294506],"study_design_scores_gemma":[0.002847755,0.000601547,0.7931803,0.0004773273,0.0001927204,0.000004880446,0.0001154931,0.170204,0.03168147,0.0006271154,0.000006955202,0.00006043642],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997704,0.00008630714,0.0002139392,0.0005494257,0.0001012303,0.0006678444,0.000002461094,0.000007409959,0.0006674073],"genre_scores_gemma":[0.9984375,0.00002743806,0.001345995,0.00008073624,0.00004650587,0.000008652519,0.00001620105,0.000009767979,0.00002715969],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2232139,"threshold_uncertainty_score":0.2878064,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W777891328","doi":"10.2165/11588190-000000000-00000","title":"Intranasal versus Oral Administration of Lisdexamfetamine Dimesylate","year":2011,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Forensic Toxicology and Drug Analysis","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":35,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Medicine; Stimulant; Cmax; Pharmacokinetics; Crossover study; Adverse effect; Oral administration; Nasal administration; Dosing; Pharmacology; Anesthesia; Placebo","retraction":null,"screen_n_in":null,"score":{"opus":0.3306859196173997,"gpt":0.481907058468223,"spread":0.1512211388508233,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00202829,0.0001984105,0.0004380165,0.0001166477,0.0001325034,0.000005966117,0.0002464372,0.0005256766,0.001378317],"category_scores_gemma":[0.0008912276,0.0001879075,0.0002270805,0.0003417768,0.001531326,0.0001851929,0.00005427932,0.0007760026,0.0001716255],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002520945,"about_ca_system_score_gemma":0.0001893573,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000477426,"about_ca_topic_score_gemma":0.0002106632,"domain_scores_codex":[0.9970983,0.001022452,0.001070845,0.0003708098,0.0001518575,0.0002857311],"domain_scores_gemma":[0.997824,0.0009609609,0.0004459913,0.0002756602,0.0001681767,0.0003252301],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0281938,0.004919587,0.5785218,0.00030096,0.004096012,0.0002301102,0.0100569,0.000526013,0.009508991,0.1386172,0.0514333,0.1735952],"study_design_scores_gemma":[0.02206851,0.005376029,0.4688793,0.00009449098,0.004500395,0.00003118816,0.0012647,0.02937837,0.3799271,0.04976535,0.03698604,0.001728598],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9882582,0.00009916392,0.0002363971,0.0009175249,0.002450823,0.0002176668,0.00002416181,0.00009418224,0.00770192],"genre_scores_gemma":[0.9958802,0.0001134673,0.002040376,0.0009163835,0.0002435835,0.00001642769,0.0001096593,0.00001640985,0.00066344],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3704181,"threshold_uncertainty_score":0.9995345,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2004371282","doi":"10.2165/00044011-200121090-00005","title":"Comparison of Salmeterol/Fluticasone Propionate Combination with Budesonide in Patients with Mild-to-Moderate Asthma","year":2001,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Salmeterol; Fluticasone propionate; Budesonide; Tolerability; Morning; Evening; Fluticasone; Asthma; Combination therapy; Anesthesia; Spirometry; Internal medicine; Adverse effect","retraction":null,"screen_n_in":null,"score":{"opus":0.04419868005731209,"gpt":0.3507770570434884,"spread":0.3065783769861763,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003520606,0.0001704853,0.000504938,0.0001644926,0.00005378704,0.00001464943,0.00007834922,0.00009560168,0.00001555091],"category_scores_gemma":[0.0003130925,0.0001178963,0.00005290647,0.0004811162,0.0003036173,0.0001420915,0.000026622,0.0002527987,0.00002262348],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005521537,"about_ca_system_score_gemma":0.0001719752,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002249441,"about_ca_topic_score_gemma":0.00006231955,"domain_scores_codex":[0.9979905,0.0002059309,0.0007578906,0.0003533589,0.0004832393,0.0002090038],"domain_scores_gemma":[0.9986154,0.0001546556,0.0002743268,0.0002585266,0.0003641211,0.0003330119],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002219489,0.001245085,0.9881191,0.00006458074,0.00002475102,0.000007062561,0.000202589,0.0003163881,0.00006472285,0.00006987707,0.0001837082,0.007482667],"study_design_scores_gemma":[0.005645608,0.002654108,0.9865839,0.0005399392,0.0000557003,0.000001053521,0.00008215448,0.003105433,0.0007443933,0.0001118496,0.0003294183,0.0001463853],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9976332,0.00003275332,0.0003230442,0.0008825403,0.00005810791,0.00091244,0.00000553103,0.00004088378,0.0001114643],"genre_scores_gemma":[0.9965289,0.000004196869,0.002299144,0.0008769348,0.00004363715,0.00003383799,0.0001052433,0.0000252226,0.00008288663],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007336282,"threshold_uncertainty_score":0.4807673,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W87703995","doi":"10.2165/00044011-200828100-00003","title":"Evaluation of a New Formulation of Fenofibric Acid, ABT-335, Co-Administered with Statins","year":2008,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Abbott (Canada)","funders":"","keywords":"Medicine; Atorvastatin; Combination therapy; Rosuvastatin; Fenofibrate; Rosuvastatin Calcium; Simvastatin; Statin; Pharmacotherapy; Internal medicine; Pharmacology; Clinical endpoint; Clinical trial; Fibrate; Randomized controlled trial; Gastroenterology","retraction":null,"screen_n_in":null,"score":{"opus":0.2015735245686092,"gpt":0.4060830115815734,"spread":0.2045094870129643,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003559136,0.0001245683,0.0005163919,0.00009841576,0.0000580282,0.000003866913,0.00005933833,0.000159722,0.00004190073],"category_scores_gemma":[0.001193772,0.00009916547,0.0001961969,0.0003225898,0.000223778,0.0001500003,0.00001357483,0.0002093908,0.00001038391],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007977495,"about_ca_system_score_gemma":0.002047275,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002588943,"about_ca_topic_score_gemma":0.00004397328,"domain_scores_codex":[0.9967354,0.0004049711,0.0009876419,0.0002655415,0.00146088,0.0001455554],"domain_scores_gemma":[0.9977449,0.000119531,0.0005563613,0.0004722626,0.0008418835,0.0002651005],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002034428,0.000979573,0.5965438,0.001466085,0.00127484,0.00001832905,0.009023709,0.0007457176,0.01028042,0.00145458,0.005659563,0.370519],"study_design_scores_gemma":[0.008434727,0.001650495,0.9401158,0.0004075356,0.0008829276,0.0000517941,0.0001997839,0.006992727,0.03869976,0.001891215,0.0005060986,0.0001671131],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9953297,0.0002578513,0.001724791,0.0005692948,0.00007411443,0.001106366,0.000009248368,0.00002846121,0.0009001189],"genre_scores_gemma":[0.9920637,0.00007913547,0.007043595,0.0002396371,0.0002267233,0.00002051093,0.0001641559,0.00001982704,0.0001427428],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3703518,"threshold_uncertainty_score":0.404385,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2904095541","doi":"10.1007/s40261-018-0721-6","title":"A Literature Review of Psychotropic Medications and Alcohol as Risk Factors for Falls in Community Dwelling Older Adults","year":2018,"lang":"en","type":"review","venue":"Clinical Drug Investigation","topic":"Balance, Gait, and Falls Prevention","field":"Health Professions","cited_by":34,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Saskatchewan; Regional Municipality of Waterloo; University of Waterloo","funders":"University of Waterloo","keywords":"Medicine; Psychiatry; CINAHL; Psychotropic drug; Benzodiazepine; Poison control; Drug; Internal medicine; Psychological intervention; Emergency medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1272800725741716,"gpt":0.4923098426836026,"spread":0.3650297701094309,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.006179482,0.0003796078,0.001957963,0.000198376,0.0004649911,0.00001203154,0.0004227165,0.001060251,0.00001473075],"category_scores_gemma":[0.006879703,0.0002951553,0.0004968561,0.0005989764,0.0004149894,0.0001618919,0.0001083648,0.003107152,0.000044203],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007983291,"about_ca_system_score_gemma":0.0005255275,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002152114,"about_ca_topic_score_gemma":0.000224622,"domain_scores_codex":[0.9884771,0.007053458,0.003371054,0.0005232038,0.0002440825,0.0003311785],"domain_scores_gemma":[0.9885327,0.006930677,0.003011231,0.0008151017,0.0004378959,0.0002723536],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0000278807,0.0006871767,0.0118294,0.7027577,0.0002359349,5.656433e-7,0.007674543,1.67689e-8,2.706339e-7,0.0006053094,0.01453166,0.2616495],"study_design_scores_gemma":[0.00114673,0.0001103322,0.02168636,0.7414784,0.0008041642,8.61405e-7,0.0003096177,0.00003172471,3.832588e-8,0.003511745,0.2306413,0.000278615],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0161783,0.9767377,0.00006250235,0.0002086627,0.0008929784,0.005355269,0.0003734298,0.0000465967,0.0001445891],"genre_scores_gemma":[0.0002733858,0.9932524,0.0008462082,0.0008348626,0.0004733766,0.0007948023,0.003247572,0.00004919523,0.0002282158],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.2613709,"threshold_uncertainty_score":0.9999501,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1971473849","doi":"10.1007/s40261-013-0085-x","title":"Pharmacokinetics, Tolerability, and Safety of Intranasal Administration of Reformulated OxyContin® Tablets Compared with Original OxyContin® Tablets in Healthy Adults","year":2013,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Purdue Pharma (Canada)","funders":"Purdue Pharma; Purdue University","keywords":"Tolerability; Medicine; Pharmacokinetics; Crossover study; Adverse effect; Dosing; Nasal administration; Anesthesia; Area under the curve; Pharmacology","retraction":null,"screen_n_in":null,"score":{"opus":0.02686607623620742,"gpt":0.3231715285779246,"spread":0.2963054523417172,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001180478,0.0001837453,0.0006750258,0.0001382866,0.00003655218,0.00001554389,0.0001020394,0.0001197883,0.00008470248],"category_scores_gemma":[0.0004113812,0.0001509717,0.00005429571,0.0003518607,0.0004648152,0.0002397876,0.00003964554,0.0003246003,0.000004974515],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004688076,"about_ca_system_score_gemma":0.0002035157,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006593065,"about_ca_topic_score_gemma":0.0003186592,"domain_scores_codex":[0.9972837,0.0002358815,0.00153811,0.0003818967,0.0003127356,0.0002477047],"domain_scores_gemma":[0.998242,0.0003382036,0.0005397475,0.000285881,0.000341073,0.0002530862],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007394506,0.000537892,0.9825737,0.001034011,0.00007490897,0.000007315224,0.0006151949,0.00007858089,0.001725955,0.0003985341,0.0009177017,0.004641733],"study_design_scores_gemma":[0.009360789,0.001431383,0.9604173,0.0007634462,0.00009785921,0.000002045821,0.0001723257,0.02425757,0.002172382,0.0005788662,0.0005802625,0.0001657781],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9937805,0.00008038388,0.0001400398,0.004057311,0.0001067713,0.001423548,0.000009831087,0.0000341142,0.0003674872],"genre_scores_gemma":[0.9957991,0.0001905862,0.003006787,0.0006081469,0.00008870366,0.000026487,0.0001802821,0.00001571371,0.00008415414],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02417899,"threshold_uncertainty_score":0.6156447,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2807503561","doi":"10.1007/s40261-018-0660-2","title":"Multiple Rising Doses of Oral BI 425809, a GlyT1 Inhibitor, in Young and Elderly Healthy Volunteers: A Randomised, Double-Blind, Phase I Study Investigating Safety and Pharmacokinetics","year":2018,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Amino Acid Enzymes and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"Boehringer Ingelheim","keywords":"Pharmacokinetics; Tolerability; Medicine; Adverse effect; Placebo; Pharmacology; Morning; Evening; Dosing; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.05515474089450226,"gpt":0.380198570377732,"spread":0.3250438294832297,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001799736,0.0002367888,0.0004786488,0.0001008628,0.000133817,0.00003944118,0.0001220256,0.000187479,0.000003193089],"category_scores_gemma":[0.001066854,0.0002237492,0.00007049721,0.0002270361,0.0008839829,0.0000290695,0.0001677493,0.0002662725,0.000001244034],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001229596,"about_ca_system_score_gemma":0.0001486195,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007959134,"about_ca_topic_score_gemma":0.001431702,"domain_scores_codex":[0.9973838,0.0004175907,0.001155486,0.0005747785,0.0001886155,0.0002797537],"domain_scores_gemma":[0.9987511,0.0001577171,0.0003603843,0.0002608194,0.0001787168,0.0002912743],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.03464098,0.00108002,0.6922126,0.0001877861,0.0001828982,0.00000489716,0.004967809,0.00005038781,0.239911,0.00007568218,0.0005839019,0.02610209],"study_design_scores_gemma":[0.6228663,0.008762184,0.1292284,0.0004446977,0.0005230439,0.00003334345,0.004920708,0.0170853,0.2099736,0.0004773086,0.004318698,0.001366424],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9970641,0.0008414512,0.0003125818,0.0002589608,0.0003517468,0.001085191,0.00001594938,0.00001633417,0.00005376034],"genre_scores_gemma":[0.9960623,0.0004877142,0.00241918,0.0003632107,0.0004968351,0.00003181282,0.00006937391,0.00002777901,0.0000418306],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5882253,"threshold_uncertainty_score":0.9124227,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2059623829","doi":"10.1007/bf03261913","title":"Effect of Ketoconazole on the Pharmacokinetic Profile of Buprenorphine following Administration of a Once-Weekly Buprenorphine Transdermal System","year":2012,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":31,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Purdue Pharma (Canada)","funders":"","keywords":"Ketoconazole; Medicine; Buprenorphine; Cmax; Pharmacokinetics; Placebo; Crossover study; Pharmacology; Confidence interval; Transdermal; Area under the curve; Anesthesia; Internal medicine; Opioid","retraction":null,"screen_n_in":null,"score":{"opus":0.1064207797096589,"gpt":0.4382565665593631,"spread":0.3318357868497042,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00604179,0.0003200526,0.0007887338,0.0001207485,0.0001222751,0.000006657837,0.0004217228,0.000284381,0.0002454942],"category_scores_gemma":[0.0005593367,0.0002333179,0.0004580106,0.0003883893,0.0006057911,0.0001537373,0.00006436494,0.0007383915,0.00003016263],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002887877,"about_ca_system_score_gemma":0.0001467661,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000179921,"about_ca_topic_score_gemma":0.00000140866,"domain_scores_codex":[0.9944679,0.002684447,0.001697821,0.0003084475,0.0004373776,0.0004040307],"domain_scores_gemma":[0.9946814,0.003488692,0.0009809522,0.0003423176,0.0001598892,0.0003467915],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.004030833,0.001806106,0.08532561,0.002242987,0.001082954,0.00001082048,0.002644867,0.001450156,0.8517414,0.005986188,0.002416053,0.04126202],"study_design_scores_gemma":[0.003880614,0.0007929891,0.01370611,0.0001817934,0.001065648,0.000005483314,0.00008814583,0.01099709,0.9673689,0.00008702775,0.001609391,0.0002168322],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9931711,0.0006927102,0.00005487024,0.0006994632,0.001933771,0.001532765,0.0001610712,0.00004612841,0.001708129],"genre_scores_gemma":[0.9985144,0.00009021947,0.0001398661,0.0003296298,0.0005474792,0.0001564567,0.00007561308,0.00003340878,0.0001129694],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1156275,"threshold_uncertainty_score":0.9514429,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2009098521","doi":"10.2165/00044011-200019030-00007","title":"LIPI-WATCH, a Belgian/Luxembourg Survey on Achievement of European Atherosclerosis Society Lipid Goals","year":2000,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital Saint-Luc","funders":"European Atherosclerosis Society","keywords":"Medicine; Body mass index; Internal medicine; Diabetes mellitus; Coronary heart disease; Lipid profile; Risk factor; Cholesterol; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.07260013807781045,"gpt":0.3247633831257585,"spread":0.252163245047948,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007080455,0.0002147356,0.0006522722,0.00002698023,0.000118595,0.00001989751,0.0001586201,0.0001532826,0.0002094282],"category_scores_gemma":[0.000600879,0.0001784693,0.0006765706,0.0003154994,0.0003350145,0.0000712565,0.00004453656,0.0004834479,0.0002959515],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000739705,"about_ca_system_score_gemma":0.000186976,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006688391,"about_ca_topic_score_gemma":0.0000415584,"domain_scores_codex":[0.9960306,0.001356519,0.001136693,0.0005066014,0.0006665821,0.0003030135],"domain_scores_gemma":[0.9979849,0.0003222563,0.0002525043,0.0008293989,0.0001785628,0.000432316],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005014716,0.001720859,0.6900961,0.0004875055,0.0008347196,0.000005387667,0.001797168,0.0001383112,0.00201081,0.0002285184,0.06255753,0.2396216],"study_design_scores_gemma":[0.002156416,0.0005930195,0.9827774,0.0004089754,0.0001189623,0.000001297686,0.00003753886,0.0001468729,0.001880183,0.00007943282,0.0116289,0.0001710766],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930681,0.00008562094,0.00003971117,0.003978184,0.000229436,0.0006777876,0.00004230909,0.00008421774,0.001794606],"genre_scores_gemma":[0.9879802,0.001160233,0.00104762,0.006361412,0.001123489,0.00001883093,0.0002357111,0.0000584665,0.002014055],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2926812,"threshold_uncertainty_score":0.7277768,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2097671393","doi":"10.1007/s40261-013-0080-2","title":"Cross-Over, Open-Label Trial of the Effects of Gabapentin versus Pregabalin on Painful Peripheral Neuropathy and Health-Related Quality of Life in Haemodialysis Patients","year":2013,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Dialysis and Renal Disease Management","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"McGill University","keywords":"Pregabalin; Gabapentin; Medicine; Neuropathic pain; Anesthesia; Peripheral neuropathy; Quality of life (healthcare); McGill Pain Questionnaire; Crossover study; Randomized controlled trial; Internal medicine; Visual analogue scale; Diabetes mellitus","retraction":null,"screen_n_in":null,"score":{"opus":0.1008185898507183,"gpt":0.3959633070533829,"spread":0.2951447172026646,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002243722,0.0001325992,0.0008147694,0.00007509811,0.00003829101,0.00002242627,0.0001879847,0.00008808548,0.00002896171],"category_scores_gemma":[0.00766433,0.00009001319,0.0001785826,0.0003490476,0.0004477134,0.0001095657,0.0001996271,0.0001900663,0.000002520481],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003596214,"about_ca_system_score_gemma":0.000157181,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001757069,"about_ca_topic_score_gemma":0.00006602539,"domain_scores_codex":[0.9957293,0.001439435,0.001940315,0.0003085144,0.0004440139,0.000138408],"domain_scores_gemma":[0.9969726,0.001000643,0.001231767,0.0004151279,0.0001676616,0.0002121733],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01911934,0.005214609,0.9502025,0.00140607,0.0002901232,7.311436e-7,0.0006390237,0.00006949953,0.0003596873,0.0006229018,0.0009832676,0.0210922],"study_design_scores_gemma":[0.08778773,0.001587093,0.9084076,0.0003903578,0.0001090933,9.725115e-9,0.00002102133,0.001143675,0.0001801692,0.0002950229,0.00001011273,0.00006807317],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958248,0.00007267926,0.000001714998,0.0009819724,0.000586461,0.002337069,0.000009967731,0.000006498804,0.0001788397],"genre_scores_gemma":[0.9989272,0.00006264205,0.00006156899,0.0007016485,0.00003709104,0.00004634704,0.00004641851,0.00001120734,0.0001058362],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0686684,"threshold_uncertainty_score":0.9175472,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2021841808","doi":"10.2165/11537460-000000000-00000","title":"Mycophenolate Mofetil in the Treatment of Adults with Advanced Rheumatoid Arthritis","year":2010,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Mycophenolate; Rheumatoid arthritis; Internal medicine; Ciclosporin; Placebo; Adverse effect; Rheumatism; Mycophenolic acid; Gastroenterology; Refractory (planetary science); Transplantation; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.01971433525382949,"gpt":0.3106981557827874,"spread":0.2909838205289579,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005645874,0.0001300279,0.0003489846,0.00007112181,0.00005914335,0.00001682842,0.0001047752,0.00006674514,0.00006530171],"category_scores_gemma":[0.0003768624,0.00007679347,0.0000890699,0.0002257437,0.0006066692,0.0001139958,0.000008484722,0.0003184792,0.000028689],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001440164,"about_ca_system_score_gemma":0.000155029,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001903153,"about_ca_topic_score_gemma":0.0008235285,"domain_scores_codex":[0.9984576,0.0001750912,0.0005833569,0.0002472687,0.0003238219,0.0002129044],"domain_scores_gemma":[0.998659,0.0005218424,0.0001423417,0.0003916436,0.0001192925,0.0001658724],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.002535264,0.001622123,0.3148961,0.00005826542,0.00008671359,0.00006884075,0.01490371,0.00001102162,0.003150301,0.002749185,0.000336701,0.6595818],"study_design_scores_gemma":[0.05653011,0.01265569,0.8597792,0.003431561,0.00001240338,0.0002057411,0.006034533,0.001813949,0.01743505,0.01179709,0.02976732,0.0005373151],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947809,0.001612991,0.000005756872,0.002234373,0.0001207332,0.0007084193,0.000006991967,0.00002861663,0.0005012386],"genre_scores_gemma":[0.9575685,0.04038909,0.001611773,0.0001919659,0.00005371269,0.00009929602,0.00004157377,0.00001502253,0.00002911377],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6590444,"threshold_uncertainty_score":0.3131547,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2795474249","doi":"10.1007/s40261-018-0648-y","title":"Translating Benzodiazepine Utilization Data into Meaningful Population Exposure: Integration of Two Metrics for Improved Reporting","year":2018,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Sleep and related disorders","field":"Psychology","cited_by":27,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Manitoba Health; University of Manitoba","funders":"","keywords":"Defined daily dose; Zopiclone; Medicine; Zolpidem; Benzodiazepine; Metric (unit); Population; Consumption (sociology); Pharmacology; Drug; Statistics; Environmental health; Hypnotic; Internal medicine; Mathematics; Operations management; Insomnia; Engineering","retraction":null,"screen_n_in":null,"score":{"opus":0.2832879371559091,"gpt":0.4736644323673557,"spread":0.1903764952114466,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.003893964,0.0001762804,0.0003750183,0.0002256624,0.0001906966,0.00002918133,0.0002904947,0.0002981347,0.00004826432],"category_scores_gemma":[0.01308861,0.0001660858,0.0001242091,0.0008258155,0.0002644355,0.0003989217,0.00005326311,0.0002660031,0.00001098214],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000337701,"about_ca_system_score_gemma":0.00006865402,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006099645,"about_ca_topic_score_gemma":0.0006483451,"domain_scores_codex":[0.9957033,0.0003615406,0.002874024,0.000653422,0.0001924784,0.0002152819],"domain_scores_gemma":[0.9952915,0.0007258583,0.002635849,0.0007444558,0.0004891707,0.0001131617],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.0002563644,0.0003492454,0.1097113,0.00008633491,0.0003633843,6.392146e-7,0.01079949,0.00008379583,0.009194926,0.01176146,0.001868631,0.8555244],"study_design_scores_gemma":[0.01234917,0.001777849,0.1255196,0.000532455,0.001539177,0.000006792964,0.00544431,0.7199466,0.009167132,0.1206013,0.002009522,0.001106007],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8173095,0.0004058563,0.1773437,0.000880872,0.002286103,0.0009184513,0.00002288704,0.0001393248,0.0006933108],"genre_scores_gemma":[0.9617444,0.00002109357,0.03447694,0.0002689975,0.0005786794,0.00003132846,0.002768972,0.00003717195,0.00007242549],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8544185,"threshold_uncertainty_score":0.9952245,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2006812895","doi":"10.1007/s40261-014-0192-3","title":"Abuse Potential of Intravenous Oxycodone/Naloxone Solution in Nondependent Recreational Drug Users","year":2014,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Purdue Pharma (Canada)","funders":"Purdue Pharma; Regeneron Pharmaceuticals; Purdue University","keywords":"Oxycodone; Medicine; (+)-Naloxone; Placebo; Anesthesia; Opioid; Tolerability; Narcotic antagonist; Crossover study; Opioid antagonist; Pharmacology; Adverse effect; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.02601214314395318,"gpt":0.3055863440596846,"spread":0.2795742009157314,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001293301,0.0001902407,0.0004866412,0.0002002395,0.00005423204,0.00001316173,0.0001130474,0.0001679592,0.00006732294],"category_scores_gemma":[0.0007066852,0.0001825548,0.0001748494,0.0002663467,0.0003012354,0.0001424535,0.00003420315,0.0003587256,0.00008780306],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000163764,"about_ca_system_score_gemma":0.0002674521,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000492248,"about_ca_topic_score_gemma":0.0002286303,"domain_scores_codex":[0.9972727,0.0003785479,0.001158313,0.0004379358,0.0005000786,0.0002523699],"domain_scores_gemma":[0.9984999,0.0003351723,0.0003494098,0.0003796862,0.000188619,0.0002471602],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001188218,0.004160525,0.938635,0.0004478832,0.0003122144,0.00003691849,0.008088411,0.001412507,0.01378867,0.004346533,0.002851041,0.02473211],"study_design_scores_gemma":[0.005538564,0.0003891537,0.9680305,0.0004279555,0.0002251489,0.00001140287,0.0003632481,0.01466816,0.004852005,0.004939795,0.0003300442,0.0002240946],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9940865,0.00009517599,0.001402388,0.002865976,0.0004231774,0.0006575044,0.000009345913,0.00005662667,0.0004032874],"genre_scores_gemma":[0.9925529,0.0002054796,0.005580941,0.000565484,0.0002537644,0.00004030092,0.0004402898,0.00002806347,0.0003327891],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02939546,"threshold_uncertainty_score":0.744437,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W645710337","doi":"10.1007/s40261-015-0300-z","title":"Recombinant Human C1 Esterase Inhibitor in the Management of Hereditary Angioedema","year":2015,"lang":"en","type":"review","venue":"Clinical Drug Investigation","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Valeant Pharmaceuticals International; CSL Behring; BioCryst; Viropharma","keywords":"Hereditary angioedema; Medicine; Danazol; Pharmacology; C1-inhibitor; Population; Angioedema; Pharmacokinetics; Gastroenterology; Internal medicine; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.1939833983334935,"gpt":0.441416956826433,"spread":0.2474335584929395,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003656806,0.0004302096,0.00193181,0.0002288171,0.00007958569,0.00002980442,0.0003672596,0.00041896,0.00003005609],"category_scores_gemma":[0.0002155399,0.0002907506,0.0007544816,0.0006530868,0.0004131193,0.0001331717,0.0001276661,0.0006188547,0.00005548239],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001275097,"about_ca_system_score_gemma":0.0004171065,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009493031,"about_ca_topic_score_gemma":0.00002816137,"domain_scores_codex":[0.9950388,0.0007803102,0.002651563,0.000607763,0.0006162967,0.0003052307],"domain_scores_gemma":[0.9972012,0.0005654823,0.0009626775,0.0008528231,0.0001463782,0.000271451],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000325598,0.0006873172,0.003977752,0.02145153,0.0003611495,0.0002289386,0.0006897002,0.000001543945,2.154931e-7,0.002610371,0.03920789,0.930751],"study_design_scores_gemma":[0.002497042,0.00049999,0.009801217,0.05440041,0.002973136,0.00007557708,0.000368766,0.00006191991,0.000003747498,0.005465945,0.9232843,0.0005679539],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01391331,0.980304,0.000004196583,0.0007934954,0.00138979,0.002432203,0.00002253354,0.00006231511,0.001078126],"genre_scores_gemma":[0.00224115,0.991605,0.0007597913,0.0005684919,0.001327689,0.0002047506,0.00150576,0.00008385098,0.001703459],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9301831,"threshold_uncertainty_score":0.9999545,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3006624590","doi":"10.1007/s40261-020-00894-7","title":"Mechanisms of Cannabinoids and Potential Applicability to Skin Diseases","year":2020,"lang":"en","type":"review","venue":"Clinical Drug Investigation","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Synthetic cannabinoids; Cannabis; Acne; Pharmacology; Cannabinoid; Bioinformatics; Dermatology; Psychiatry; Biology; Receptor; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.05416861842926524,"gpt":0.3990094038006741,"spread":0.3448407853714089,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009303049,0.0003697049,0.002370841,0.0001664291,0.0000658991,0.00003440432,0.0002326232,0.0003844167,0.00006784186],"category_scores_gemma":[0.002080306,0.0002939437,0.0007507292,0.0006004677,0.0006054555,0.00004656563,0.0003235304,0.0007606851,0.00004796997],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001134268,"about_ca_system_score_gemma":0.001516713,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008885958,"about_ca_topic_score_gemma":0.000007232526,"domain_scores_codex":[0.996093,0.0004883643,0.001582124,0.0009105995,0.000621599,0.000304267],"domain_scores_gemma":[0.9971549,0.0001067248,0.0003796755,0.000610437,0.0002610629,0.001487212],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006458419,0.0001541239,0.0001002491,0.01889678,0.0001189906,0.00002132492,0.00004612748,4.475815e-7,0.00001353079,0.0009833735,0.03164607,0.9479544],"study_design_scores_gemma":[0.0005303521,0.0005117519,0.002986799,0.003211514,0.001400052,0.00002088049,0.00003172503,0.00005606386,0.00003206245,0.002997814,0.9879099,0.0003110821],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002052828,0.9806015,0.000504022,0.01177639,0.0003485897,0.004158064,0.0003796765,0.00008927807,0.000089591],"genre_scores_gemma":[0.0009794262,0.9943093,0.0007997591,0.000948295,0.0006269375,0.0004644254,0.0004052942,0.0000826353,0.001383899],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9562638,"threshold_uncertainty_score":0.9999512,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2515349100","doi":"10.1007/s40261-016-0457-0","title":"Antiepileptic Drug Removal by Continuous Renal Replacement Therapy: A Review of the Literature","year":2016,"lang":"en","type":"review","venue":"Clinical Drug Investigation","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Levetiracetam; Renal replacement therapy; Carbamazepine; Lacosamide; Phenytoin; Valproic Acid; Dosing; Intensive care medicine; Intensive care unit; Acute kidney injury; Gabapentin; Topiramate; Pharmacology; Epilepsy; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.06827889689270568,"gpt":0.4096651750632858,"spread":0.3413862781705801,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00314935,0.0004831984,0.0030918,0.00005341088,0.0001111365,0.00001918518,0.0003542847,0.0003334816,0.0001089742],"category_scores_gemma":[0.004116113,0.0002077675,0.001408143,0.0005052854,0.0007851062,0.00005908572,0.0001946834,0.001117691,0.00004233293],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009184865,"about_ca_system_score_gemma":0.0003630246,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003428765,"about_ca_topic_score_gemma":3.371984e-7,"domain_scores_codex":[0.9943628,0.002004834,0.002135459,0.000660813,0.00054543,0.0002906951],"domain_scores_gemma":[0.9952545,0.001884906,0.001601995,0.0007340865,0.000278483,0.0002460901],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005794784,0.0001947426,0.0000625046,0.0623198,0.0004688459,0.00001623423,0.00004395349,4.301246e-9,0.00002309188,0.00005030094,0.3486936,0.588069],"study_design_scores_gemma":[0.0007728179,0.0001997022,0.00003517876,0.3013319,0.0008373023,0.00002727907,0.00000156146,9.309346e-7,0.00003656242,0.0001151607,0.6964781,0.0001634731],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0006345114,0.9886137,0.000002105914,0.005972208,0.000715045,0.003331556,0.0001288678,0.0000520177,0.0005499905],"genre_scores_gemma":[0.00003105422,0.9853826,0.00008359995,0.00914094,0.0006215743,0.000149513,0.0001715895,0.00003888741,0.004380269],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.5879055,"threshold_uncertainty_score":0.8472513,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3005447570","doi":"10.1007/s40261-020-00893-8","title":"Evaluation of the Efficacy of BI 425809 Pharmacotherapy in Patients with Schizophrenia Receiving Computerized Cognitive Training: Methodology for a Double-blind, Randomized, Parallel-group Trial","year":2020,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Boehringer Ingelheim (Canada); Queen's University","funders":"Boehringer Ingelheim","keywords":"Pharmacotherapy; Randomized controlled trial; Schizophrenia (object-oriented programming); Medicine; Cognition; Physical therapy; Double blind; Psychiatry; Internal medicine; Placebo; Alternative medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.3507005627858176,"gpt":0.4565512925816959,"spread":0.1058507297958783,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.008323349,0.0001812951,0.001126177,0.0001099583,0.0000478363,0.000009757,0.0001363276,0.0001187736,0.00002443743],"category_scores_gemma":[0.009911449,0.0001108525,0.0003413154,0.0004449659,0.0006229893,0.00007891961,0.00003435637,0.0003173694,0.000001355279],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004946678,"about_ca_system_score_gemma":0.0008352956,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002689437,"about_ca_topic_score_gemma":0.00002776524,"domain_scores_codex":[0.9933318,0.003998485,0.001234513,0.0004000034,0.00083328,0.0002018849],"domain_scores_gemma":[0.9905927,0.007532546,0.0007242894,0.0001850692,0.0007490708,0.0002162872],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9539106,0.0006462085,0.007504936,0.00005081359,0.0005989902,3.862068e-7,0.00135227,0.0001062203,0.0001596564,0.0002073597,0.00001745645,0.03544508],"study_design_scores_gemma":[0.9252137,0.00217678,0.05643554,0.0002915575,0.001040889,2.993192e-7,0.00006955244,0.0118409,0.001272728,0.001562985,0.000002442677,0.0000926592],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9831721,0.00007713773,0.002512095,0.002622234,0.000203275,0.01136545,0.00001715514,0.00001853611,0.00001207898],"genre_scores_gemma":[0.9748842,0.00002288127,0.02367149,0.000367179,0.0002353795,0.000628709,0.0001651864,0.00002239768,0.00000257866],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0489306,"threshold_uncertainty_score":0.9984285,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2077423491","doi":"10.2165/11598940-000000000-00000","title":"Cost-Effectiveness and Cost-Utility of Beclomethasone/Formoterol versus Fluticasone Propionate/Salmeterol in Patients with Moderate to Severe Asthma","year":2012,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Canadian Institute for Theoretical Astrophysics; Chiesi Farmaceutici","keywords":"Salmeterol; Fluticasone propionate; Medicine; Formoterol; Asthma; Exacerbation; Fluticasone; Quality-adjusted life year; Quality of life (healthcare); Pediatrics; Cost effectiveness; Emergency medicine; Budesonide; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.08262178632127089,"gpt":0.3634312461936802,"spread":0.2808094598724094,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009381258,0.0001835527,0.0004688546,0.0001075702,0.00005025622,0.0000108114,0.0000611224,0.0001350913,0.00001698675],"category_scores_gemma":[0.0009833309,0.0001364102,0.00006060456,0.0002608266,0.0003308296,0.0002561084,0.00006335626,0.0002572908,0.00001229325],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000575202,"about_ca_system_score_gemma":0.0001225426,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002482875,"about_ca_topic_score_gemma":0.00001114554,"domain_scores_codex":[0.9980938,0.0004333503,0.0005312033,0.0003297818,0.0003236246,0.0002882669],"domain_scores_gemma":[0.9982296,0.0005373631,0.0001571752,0.0002588089,0.000218272,0.0005987502],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007002287,0.0005523148,0.9445055,0.0001732353,0.00003628827,0.000001540533,0.0002104834,0.00003006905,0.00005169659,0.00001871781,0.00005726156,0.04736067],"study_design_scores_gemma":[0.00898603,0.001053042,0.9872283,0.0002664767,0.00006376782,0.000001011031,0.00006187987,0.001082569,0.0008148675,0.00004889709,0.0002471876,0.0001459251],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968282,0.00007609506,0.0002715829,0.0001676837,0.0001852713,0.002355308,0.00003935167,0.00002768861,0.00004884591],"genre_scores_gemma":[0.998367,0.000004406434,0.0009309673,0.0004118491,0.0000713177,0.0001166557,0.00006572002,0.0000209292,0.00001116282],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04721474,"threshold_uncertainty_score":0.5562647,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2059248961","doi":"10.2165/11599870-000000000-00000","title":"Randomized Open-Label Drug-Drug Interaction Trial of Dextromethorphan/Quinidine and Paroxetine in Healthy Volunteers","year":2012,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Respiratory and Cough-Related Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto Public Health","funders":"","keywords":"Dextromethorphan; Paroxetine; CYP2D6; Medicine; Pharmacokinetics; Pharmacology; Quinidine; Drug interaction; Randomized controlled trial; Crossover study; Anesthesia; Internal medicine; Placebo; Cytochrome P450; Serotonin","retraction":null,"screen_n_in":null,"score":{"opus":0.1980616557976609,"gpt":0.4780799159940573,"spread":0.2800182601963964,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01626685,0.0001996545,0.001158639,0.0002741438,0.00008099146,0.00003346289,0.000180284,0.000201227,0.00009054337],"category_scores_gemma":[0.009132238,0.0001604839,0.0001310561,0.0005292728,0.0007062134,0.0005398485,0.0001575791,0.0009969503,0.00003949122],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007758835,"about_ca_system_score_gemma":0.0002942512,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003119551,"about_ca_topic_score_gemma":0.00003702863,"domain_scores_codex":[0.9938326,0.003034809,0.001908289,0.0004063063,0.0004357552,0.0003821894],"domain_scores_gemma":[0.9948643,0.003480383,0.0004982301,0.0003582077,0.0002034948,0.0005954219],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9478872,0.002040055,0.03021063,0.0002895037,0.0001532481,0.000006946804,0.001419583,0.000008364243,0.001324372,0.001070846,0.003366577,0.01222266],"study_design_scores_gemma":[0.9812476,0.00111513,0.006357824,0.0005774555,0.0002091955,0.000009351776,0.000499717,0.003490556,0.002236073,0.001272418,0.002752714,0.0002319815],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9888032,0.0009130643,0.00004818866,0.005951638,0.0009306248,0.002610319,0.000003505531,0.00002984615,0.0007095887],"genre_scores_gemma":[0.9949681,0.0008083896,0.001309501,0.001250736,0.0005746563,0.0001848635,0.00005140142,0.00002684496,0.0008255513],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03336037,"threshold_uncertainty_score":0.9992142,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1963571177","doi":"10.2165/00044011-200424090-00005","title":"Efficacy and Safety Assessment of a Novel Once-Daily Tablet Formulation of Tramadol","year":2004,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Veterinary Pharmacology and Anesthesia","field":"Veterinary","cited_by":23,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Lakeshore General Hospital; Université de Montréal","funders":"","keywords":"Tramadol; Medicine; Anesthesia; Dosing; Osteoarthritis; Analgesic; Adverse effect; Nausea; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1475034037527962,"gpt":0.4335215681560633,"spread":0.2860181644032671,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009673219,0.0001280079,0.0003392403,0.00005909769,0.00007004274,0.000006531808,0.0001139052,0.0001497235,0.00003034248],"category_scores_gemma":[0.0001712001,0.000121168,0.0000843095,0.000134215,0.0003614645,0.0002327627,0.00004833151,0.0002340619,0.000003729254],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003357914,"about_ca_system_score_gemma":0.0001396369,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003423728,"about_ca_topic_score_gemma":0.000002071632,"domain_scores_codex":[0.9983556,0.0001755127,0.0009100767,0.0002591082,0.0001606904,0.0001390039],"domain_scores_gemma":[0.9987352,0.0004755897,0.0004176313,0.000184437,0.00007667932,0.0001103995],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.00617923,0.005399031,0.246516,0.001249172,0.000438776,0.00009066167,0.004294282,0.008960868,0.6148303,0.09373888,0.0004763675,0.0178264],"study_design_scores_gemma":[0.007613589,0.00177462,0.9778321,0.0002382729,0.00009815192,0.00006178761,0.00006122934,0.006409238,0.002035147,0.003226615,0.0004677943,0.0001814111],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959019,0.00002583005,0.002244506,0.000881773,0.0001242563,0.0003781096,0.00001515193,0.00003417799,0.0003943195],"genre_scores_gemma":[0.9885964,0.00003260252,0.01087781,0.0003136814,0.00007726884,0.00001192489,0.00004648942,0.00001312909,0.00003065645],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7313161,"threshold_uncertainty_score":0.4941089,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2073529780","doi":"10.1007/s40261-013-0088-7","title":"Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Inhaled Doses of Umeclidinium in Healthy Subjects: Two Randomized Studies","year":2013,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"GlaxoSmithKline (Canada)","funders":"GlaxoSmithKline","keywords":"Medicine; Tolerability; Pharmacodynamics; Pharmacokinetics; Crossover study; Dosing; Adverse effect; Ipratropium bromide; Placebo; Anesthesia; COPD; Tiotropium bromide; Pharmacology; Bronchodilator; Internal medicine; Asthma; Lung","retraction":null,"screen_n_in":null,"score":{"opus":0.0649579216921815,"gpt":0.4054841485212134,"spread":0.3405262268290319,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002684546,0.0001992109,0.001325143,0.0001884119,0.0000432861,0.00001107396,0.00008771337,0.00008811489,0.00003888509],"category_scores_gemma":[0.004877715,0.0001688181,0.0001295377,0.0003285871,0.002704565,0.000184729,0.000212523,0.0003753413,0.000002100296],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001452944,"about_ca_system_score_gemma":0.000250479,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003455073,"about_ca_topic_score_gemma":0.00005321233,"domain_scores_codex":[0.995992,0.001124172,0.001792823,0.0004673904,0.0003698592,0.0002537481],"domain_scores_gemma":[0.9943764,0.003996702,0.0004572334,0.0002798128,0.0005411198,0.0003487299],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06608196,0.001898143,0.851154,0.008061522,0.00064177,0.00003779757,0.003272628,0.0001000452,0.0278388,0.0007756621,0.0004102343,0.03972748],"study_design_scores_gemma":[0.3877544,0.001077177,0.4994934,0.001686137,0.0008907547,0.00004900687,0.002141739,0.06333219,0.01445062,0.02851954,0.00007156587,0.0005334978],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.988607,0.004610338,0.00001417863,0.004242492,0.000172851,0.002099904,0.0000217383,0.00002343036,0.000208097],"genre_scores_gemma":[0.9928231,0.005536955,0.0009699455,0.0003840344,0.0001041419,0.00006884129,0.0000355197,0.0000213732,0.00005614634],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3516606,"threshold_uncertainty_score":0.9965081,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2900661293","doi":"10.1007/s40261-018-0726-1","title":"Drugs that Can Kill a Toddler with One Tablet or Teaspoonful: A 2018 Updated List","year":2018,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"","keywords":"Medicine; Toddler; Drug; Accidental; Intensive care medicine; Pharmacotherapy; Pediatrics; Pharmacology; Psychiatry","retraction":null,"screen_n_in":null,"score":{"opus":0.2073891630012693,"gpt":0.4188093203857671,"spread":0.2114201573844977,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001179247,0.0002233029,0.0004880343,0.0000499279,0.0002555004,0.00005877797,0.0001443677,0.0001492387,0.001311859],"category_scores_gemma":[0.001384204,0.0001438908,0.000081209,0.0004249997,0.001294095,0.0002441915,0.0001036041,0.0005666153,0.0003005689],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005934218,"about_ca_system_score_gemma":0.0002880217,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005767814,"about_ca_topic_score_gemma":0.0007114451,"domain_scores_codex":[0.9978006,0.0002604127,0.0005762151,0.0005080606,0.0004637298,0.0003909816],"domain_scores_gemma":[0.997627,0.0007514714,0.0002970126,0.0003882873,0.000296957,0.0006392958],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01065764,0.001711945,0.3792507,0.0003664603,0.001432634,0.0001180858,0.004015655,0.000002058781,0.0009635486,0.001496399,0.5516728,0.04831214],"study_design_scores_gemma":[0.006531041,0.002387743,0.1224145,0.0006040364,0.001066451,0.00004013823,0.0007073849,0.002045844,0.004850623,0.001443197,0.8573509,0.0005581359],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9239298,0.0001454261,0.00006973195,0.06412656,0.0004964039,0.0006643152,0.00002710349,0.0001787282,0.01036201],"genre_scores_gemma":[0.9551749,0.0002790668,0.003510624,0.03198291,0.001452304,0.0000388475,0.0001277403,0.00004037734,0.007393269],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3056782,"threshold_uncertainty_score":0.9996011,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1989110922","doi":"10.2165/11319800-000000000-00000","title":"Year Two Assessment of Fenofibric Acid and Moderate-Dose Statin Combination","year":2009,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Abbott (Canada)","funders":"","keywords":"Rosuvastatin; Medicine; Simvastatin; Atorvastatin; Combination therapy; Statin; Internal medicine; Pharmacology; Pharmacotherapy; Rosuvastatin Calcium; Fenofibrate; Gastroenterology; Population","retraction":null,"screen_n_in":null,"score":{"opus":0.04619729645364628,"gpt":0.3819313796049937,"spread":0.3357340831513474,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001519222,0.00008769921,0.0003494577,0.00005464895,0.0000480327,0.00001431925,0.00003357181,0.00006826279,0.000009853901],"category_scores_gemma":[0.0002764628,0.00007651596,0.00009894271,0.000146348,0.0001173966,0.00009707012,0.00001522502,0.0001943843,0.000004650431],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003762604,"about_ca_system_score_gemma":0.0002202607,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005197476,"about_ca_topic_score_gemma":0.00000387807,"domain_scores_codex":[0.9985553,0.0002349869,0.0005315659,0.0002248845,0.0003365625,0.0001167017],"domain_scores_gemma":[0.9991569,0.00007417823,0.0001646485,0.0002544885,0.0001532841,0.0001964869],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0004875079,0.001480908,0.3680443,0.0008279317,0.0003380771,0.00002820016,0.001265055,0.0002320415,0.01610434,0.07586209,0.003140654,0.5321888],"study_design_scores_gemma":[0.004092711,0.00066904,0.963661,0.0001344559,0.00009969572,0.000006334614,0.00007441845,0.01309715,0.003580446,0.01433419,0.0001509103,0.00009961861],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9939228,0.0001589517,0.001425289,0.0029065,0.00008653057,0.0004744114,0.000003410094,0.00003388391,0.0009881947],"genre_scores_gemma":[0.987886,0.0001428555,0.01064481,0.001029058,0.0001325083,0.000007491424,0.00006511815,0.000008763824,0.00008338536],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5956167,"threshold_uncertainty_score":0.312023,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2898173867","doi":"10.1007/s40261-018-0719-0","title":"Safety and Efficacy Profile of Neratinib: A Systematic Review and Meta-Analysis of 23 Prospective Clinical Trials","year":2018,"lang":"en","type":"review","venue":"Clinical Drug Investigation","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"","keywords":"Neratinib; Medicine; Oncology; Internal medicine; Adverse effect; Diarrhea; Breast cancer; Clinical trial; Hazard ratio; Nausea; Cancer; Trastuzumab; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.5943309892068062,"gpt":0.6027997922926437,"spread":0.008468803085837528,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.06409886,0.0005427499,0.03039439,0.0004118035,0.00006210569,0.0000287956,0.0003019214,0.0006759672,0.000267682],"category_scores_gemma":[0.1328702,0.0003212018,0.005073586,0.001731613,0.002064901,0.00007665584,0.000224237,0.001173347,0.00003143904],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008357505,"about_ca_system_score_gemma":0.001425435,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002404621,"about_ca_topic_score_gemma":0.00001268886,"domain_scores_codex":[0.9679076,0.01654214,0.01321115,0.001166775,0.0009011268,0.0002712031],"domain_scores_gemma":[0.9581511,0.02998761,0.007973894,0.001788882,0.001359182,0.0007393477],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00005975957,0.0001972502,0.0001964144,0.8652211,0.1257587,0.000002728395,0.00007235647,6.09068e-8,1.303663e-7,0.0001981032,0.001808214,0.00648517],"study_design_scores_gemma":[0.0008270259,0.0005953925,0.000246961,0.1132694,0.8771928,0.000008109566,0.00001099312,0.00006706677,0.000002371525,0.00007526181,0.007471811,0.000232817],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004828631,0.9836679,0.0000256129,0.0005920761,0.00009855477,0.0149612,0.0004205334,0.00002823689,0.0001576151],"genre_scores_gemma":[0.00003663808,0.9958813,0.001373477,0.0004232159,0.0002267401,0.0007383878,0.0003555042,0.00005876804,0.0009060015],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7519517,"threshold_uncertainty_score":0.999924,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4303649374","doi":"10.1007/s40261-022-01209-8","title":"The Effect of Years-Long Exposure to Low-Dose Colchicine on Renal and Liver Function and Blood Creatine Kinase Levels: Safety Insights from the Low-Dose Colchicine 2 (LoDoCo2) Trial","year":2022,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Inflammasome and immune disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"Hartstichting; Medical Research Council; ZonMw; Teva Pharmaceutical Industries","keywords":"Medicine; Colchicine; Renal function; Internal medicine; Creatinine; Creatine kinase; Blood urea nitrogen; Placebo; Liver function; Liver function tests; Bilirubin; Gastroenterology; Coronary artery disease; Endocrinology; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.0128010725083666,"gpt":0.2588416079498216,"spread":0.246040535441455,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001121191,0.0001755382,0.0002608831,0.00002959682,0.0003875477,0.00002888654,0.0001625798,0.000109252,0.00001684977],"category_scores_gemma":[0.001231244,0.0001152093,0.00009356212,0.0001459684,0.0003196224,0.000009292694,0.0002157135,0.0003183883,0.000002797788],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001107914,"about_ca_system_score_gemma":0.00006928435,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008864702,"about_ca_topic_score_gemma":0.0001545987,"domain_scores_codex":[0.9976684,0.001007124,0.0005718214,0.0003851535,0.0002193451,0.0001481841],"domain_scores_gemma":[0.9983926,0.0008282373,0.0002337474,0.0003912551,0.00006116239,0.00009293183],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.1864202,0.0007611705,0.05253641,0.0001412934,0.0009845163,0.00002765126,0.002436025,0.001239492,0.6965303,0.0006725281,0.006267434,0.05198292],"study_design_scores_gemma":[0.06401943,0.02255571,0.7984115,0.0001962455,0.0004793921,0.000004916776,0.0004127397,0.0003625943,0.1048699,0.0005500783,0.007693173,0.0004442869],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965113,0.001262558,0.00001492677,0.0007071738,0.0003402815,0.001063771,0.00004196354,0.000009077426,0.00004895941],"genre_scores_gemma":[0.9977923,0.000233329,0.00001908926,0.000972302,0.000383926,0.00009233863,0.0003041109,0.00001881934,0.0001837766],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7458751,"threshold_uncertainty_score":0.46981,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4220663751","doi":"10.1007/s40261-022-01129-7","title":"Multiple Sclerosis Relapses Following Cessation of Fingolimod","year":2022,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches","funders":"National Health and Medical Research Council; Grifols; Multiple Sclerosis Society; Multiple Sclerosis International Federation; Acorda Therapeutics; Fondation pour l'Aide à la Recherche sur la Sclérose en Plaques; Teva Pharmaceutical Industries; Biogen; Celgene; Fondazione Italiana Sclerosi Multipla; Sanofi Genzyme; University of Melbourne; Sanofi","keywords":"Fingolimod; Medicine; Smoking cessation; Multiple sclerosis; Internal medicine; Pharmacotherapy; Disease; Physical therapy; Psychiatry; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.1972093104389497,"gpt":0.3747379330857507,"spread":0.177528622646801,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.002140638,0.0001269302,0.0004283301,0.0001534074,0.0003352918,0.00001207723,0.0001558179,0.0000592358,0.0001059611],"category_scores_gemma":[0.00869269,0.0001231056,0.0003060774,0.0004986235,0.0002914659,0.000138063,0.0002877398,0.0004999117,0.00001518174],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001232948,"about_ca_system_score_gemma":0.0001846481,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002012637,"about_ca_topic_score_gemma":0.0000237083,"domain_scores_codex":[0.9971947,0.000505005,0.0008811899,0.0003700933,0.0008143812,0.0002346437],"domain_scores_gemma":[0.997415,0.001560982,0.0002995412,0.0003684134,0.0001586773,0.0001973836],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001774631,0.0003268123,0.953728,0.0001153938,0.0001597454,0.000003796801,0.001154931,0.0003353763,0.02378215,0.0001522729,0.008366724,0.01169735],"study_design_scores_gemma":[0.003141101,0.0003436373,0.977371,0.0001831071,0.00009950206,0.000001222958,0.0008369092,0.007851139,0.007657183,0.0005349904,0.001836864,0.0001433578],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949943,0.0001868787,0.00007114612,0.003116777,0.0004274074,0.0005531753,0.00002583896,0.00008341471,0.0005411006],"genre_scores_gemma":[0.9961937,0.0001448436,0.002316217,0.0005698701,0.0001578031,0.0001569753,0.0001263999,0.00002396038,0.0003102412],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02364299,"threshold_uncertainty_score":0.9996575,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1976361964","doi":"10.2165/00044011-200828110-00001","title":"Perindopril for Control of Blood Pressure in Patients with Hypertension and Other Cardiovascular Risk Factors","year":2008,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Integre de Sante et de Services Sociaux de Laval; Dr. Georges-L.-Dumont University Hospital Centre; Toronto Western Hospital; University of Toronto","funders":"","keywords":"Perindopril; Tolerability; Medicine; Blood pressure; Internal medicine; Adverse effect; Risk factor; Pharmacotherapy; Cardiology","retraction":null,"screen_n_in":null,"score":{"opus":0.04654721880806912,"gpt":0.2581235397610623,"spread":0.2115763209529932,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003975836,0.0001279424,0.0007570257,0.00005451325,0.00007476924,0.000002765353,0.00003336207,0.0001133466,0.000002827049],"category_scores_gemma":[0.0006674552,0.00008437412,0.0001572104,0.0000796235,0.0003474914,0.00005189163,0.00001927312,0.0001751687,6.199227e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000001264389,"about_ca_system_score_gemma":0.00004104368,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001598942,"about_ca_topic_score_gemma":0.000008946186,"domain_scores_codex":[0.9987839,0.00013136,0.0004325845,0.0002843472,0.0002432341,0.0001246029],"domain_scores_gemma":[0.9987814,0.0004448803,0.0001479316,0.0002432966,0.000274171,0.0001082676],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003463843,0.0002168911,0.996844,0.00007330569,0.001473533,0.000002789281,0.0002892217,0.00004189432,0.00002552221,0.00001070685,0.0003121776,0.0003635614],"study_design_scores_gemma":[0.01205988,0.0005017412,0.9770358,0.0001073515,0.005096384,0.00000363776,0.00005163145,0.0002947791,0.0003576246,0.00004510972,0.004344494,0.0001015959],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948764,0.004026833,0.00004229989,0.000148906,0.00006095515,0.0007588323,0.00003780413,0.00001911593,0.00002888938],"genre_scores_gemma":[0.9984217,0.0001554579,0.0005774858,0.0006879698,0.00006906247,0.00001958581,0.00001281253,0.000018451,0.00003751596],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01980824,"threshold_uncertainty_score":0.3440677,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3183348330","doi":"10.1007/s40261-021-01059-w","title":"Real-Life Response to Erenumab in a Therapy-Resistant Case Series of Migraine Patients From the Province of Québec, Eastern Canada","year":2021,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Migraine; Discontinuation; Tolerability; Chronic Migraine; Concomitant; Internal medicine; Pediatrics; Adverse effect","retraction":null,"screen_n_in":null,"score":{"opus":0.04766454268181435,"gpt":0.3149574475596474,"spread":0.2672929048778331,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006472882,0.0001127857,0.0004198226,0.000028877,0.00004535391,0.0000041764,0.00007303211,0.00005166338,0.000023968],"category_scores_gemma":[0.007146793,0.00007868024,0.00008104197,0.0002292844,0.000213511,0.00003639798,0.00006299717,0.0001718007,0.000001341299],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007547398,"about_ca_system_score_gemma":0.003863313,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.7813417,"about_ca_topic_score_gemma":0.986036,"domain_scores_codex":[0.9979752,0.0005136086,0.0008710338,0.0002345097,0.0002781193,0.0001275762],"domain_scores_gemma":[0.9974318,0.001487916,0.0002249479,0.0003637225,0.000332795,0.0001588383],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004145916,0.0002250484,0.952439,0.00008619321,0.00009808883,0.0002847127,0.005459202,0.000004764445,0.001760099,0.0000418793,0.03473179,0.0007233594],"study_design_scores_gemma":[0.002101388,0.0004083892,0.9849956,0.0003675096,0.00004636777,0.000005834378,0.002795071,0.0000489848,0.002518714,0.00009434326,0.006522211,0.00009558093],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9697393,0.0004667224,0.000001674485,0.02920789,0.00003463592,0.0003736531,0.0001095059,0.000006827731,0.00005980715],"genre_scores_gemma":[0.9960964,0.0001053324,0.0002313352,0.002241541,0.00006786105,0.00001765008,0.00004547532,0.00001105987,0.001183372],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2046943,"threshold_uncertainty_score":0.8555896,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4765708","doi":"10.2165/00044011-200929050-00003","title":"Diary and Patient-Reported Outcomes in Patients with Severe Overactive Bladder Switching from Tolterodine Extended Release 4 mg/day to Solifenacin Treatment","year":2009,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Bayer Canada; Astellas Pharma; GlaxoSmithKline; Pfizer","keywords":"Tolterodine; Overactive bladder; Solifenacin; Medicine; Tolerability; Urology; Adverse effect; Nocturia; Urinary urgency; Internal medicine; Urinary system","retraction":null,"screen_n_in":null,"score":{"opus":0.03128411834866037,"gpt":0.3371129593835576,"spread":0.3058288410348973,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003762235,0.0002524931,0.0005338159,0.0001515397,0.00008146766,0.00003562965,0.00005170804,0.0001088778,0.00003399595],"category_scores_gemma":[0.001073514,0.0001778989,0.00007217674,0.0002223388,0.00007604346,0.0002742047,0.0000427505,0.0003707776,0.00001827496],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001458111,"about_ca_system_score_gemma":0.0001847946,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004137905,"about_ca_topic_score_gemma":0.00007319658,"domain_scores_codex":[0.9975187,0.0003795943,0.0007499419,0.000602639,0.000436802,0.000312367],"domain_scores_gemma":[0.9980136,0.0007213528,0.0001790075,0.0003462425,0.0001436126,0.0005962037],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001855431,0.00118606,0.9176801,0.000007972606,0.000142487,0.0001023874,0.002238672,0.00001541416,0.0001953746,0.000006585274,0.0002917317,0.07627782],"study_design_scores_gemma":[0.006829818,0.003478243,0.9870467,0.0001593281,0.0001008809,0.000003691485,0.0001629427,0.0003478911,0.0005089863,0.001050857,0.0001023586,0.0002082804],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9931221,0.00004985345,0.00003057798,0.005130576,0.00008009715,0.00129858,0.00003674304,0.00004779439,0.0002036876],"genre_scores_gemma":[0.9957789,0.0000440045,0.0009366435,0.002673044,0.00006968401,0.00003661209,0.0002904014,0.00002199352,0.0001487083],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07606954,"threshold_uncertainty_score":0.7254505,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4289918702","doi":"10.1007/s40261-022-01182-2","title":"Cost–Utility Analysis of Pharmacogenetic Testing Based on CYP2C19 or CYP2D6 in Major Depressive Disorder: Assessing the Drivers of Different Cost-Effectiveness Levels from an Italian Societal Perspective","year":2022,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University","funders":"Regione Autonoma della Sardegna; Università degli Studi di Cagliari","keywords":"Major depressive disorder; Cost-effectiveness analysis; CYP2C19; Medicine; Psychiatry; Quality-adjusted life year; Cost effectiveness; Cost–utility analysis; Clinical psychology; Risk analysis (engineering); Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.3473253564150627,"gpt":0.532487651890823,"spread":0.1851622954757604,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003498549,0.0003501087,0.0008931375,0.000299146,0.0004962265,0.00002755721,0.0006317518,0.0001895419,0.00067779],"category_scores_gemma":[0.001347118,0.0002802905,0.0004168724,0.001542471,0.001001793,0.0001440208,0.0002509361,0.001403504,0.000001914371],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002241261,"about_ca_system_score_gemma":0.0004557056,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003451481,"about_ca_topic_score_gemma":0.0001475539,"domain_scores_codex":[0.9888098,0.008286045,0.001180933,0.0007832158,0.0005378176,0.0004021745],"domain_scores_gemma":[0.9886764,0.009341309,0.0009255625,0.0004242176,0.0003299202,0.0003025674],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007440804,0.001894325,0.7937901,0.00004152695,0.001087264,0.00001365924,0.002825738,0.1560466,0.02402255,0.00008155603,0.00004625479,0.01940637],"study_design_scores_gemma":[0.003528949,0.0001533101,0.5400667,0.0000224264,0.002050295,3.710271e-7,0.001605069,0.423566,0.02769043,0.0009803766,0.0001246388,0.0002115002],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947245,0.0002820243,0.0005003179,0.0006617019,0.0007443993,0.001612007,0.00129183,0.00003375606,0.0001494576],"genre_scores_gemma":[0.9975199,0.00003783146,0.0002178126,0.001474798,0.0001025036,0.0003569222,0.0002468305,0.0000314582,0.0000119716],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2675194,"threshold_uncertainty_score":0.999965,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2069015817","doi":"10.2165/00044011-200424020-00003","title":"Oxybutynin Extended Release and Tolterodine Immediate Release","year":2004,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadian Association of Radiation Oncology; McGill University; Royal Victoria Hospital","funders":"","keywords":"Oxybutynin; Tolterodine; Overactive bladder; Medicine; Urology; Extended release; Pharmacology","retraction":null,"screen_n_in":null,"score":{"opus":0.0609215298814039,"gpt":0.3717230359503727,"spread":0.3108015060689688,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001052292,0.0001608457,0.0003235773,0.0001020731,0.0001093535,0.00003230392,0.00007690956,0.0001347477,0.00006884328],"category_scores_gemma":[0.00175992,0.0001370522,0.00009696518,0.0002328457,0.0005545169,0.0001769487,0.00007939871,0.0005832618,0.0001904284],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005160114,"about_ca_system_score_gemma":0.0003365772,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001174213,"about_ca_topic_score_gemma":0.00001319038,"domain_scores_codex":[0.9980764,0.0001986316,0.0006182301,0.0004578419,0.0003387967,0.0003101208],"domain_scores_gemma":[0.9982895,0.0002995762,0.000101112,0.000323649,0.0001392626,0.0008468947],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.008420072,0.004615274,0.5629333,0.002373814,0.0006401641,0.003230836,0.006222265,0.0001655267,0.0424872,0.01338628,0.041851,0.3136743],"study_design_scores_gemma":[0.01417438,0.002479432,0.9032882,0.0005531154,0.0002252288,0.0002185373,0.0002607553,0.001413887,0.01837102,0.05298413,0.005522609,0.0005087333],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9779254,0.0005844112,0.00008692151,0.01983957,0.0001602727,0.0004723063,0.00001138262,0.00009864556,0.000821106],"genre_scores_gemma":[0.9929513,0.001129762,0.001829992,0.002247722,0.0004225778,0.00002726526,0.000152789,0.00002742482,0.001211174],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3403549,"threshold_uncertainty_score":0.5588827,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2908559747","doi":"10.1007/s40261-018-00744-7","title":"Opioid Use and Pain Control in the Elderly After Elective or Urgent Orthopaedic Surgery: A Retrospective Cohort Study","year":2019,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; McGill University Health Centre; Jewish General Hospital","funders":"","keywords":"Medicine; Delirium; Retrospective cohort study; Opioid; Morphine; Cohort; Adverse effect; Orthopedic surgery; Anesthesia; Incidence (geometry); Confidence interval; Elective surgery; Surgery; Internal medicine; Intensive care medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.02857533121576825,"gpt":0.3071452122697988,"spread":0.2785698810540306,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004856647,0.0002328985,0.0006869464,0.0001297751,0.00005350819,0.00005818536,0.00007085872,0.0001213935,0.00008933604],"category_scores_gemma":[0.006161958,0.0001439234,0.0001619024,0.0004174421,0.000187767,0.0001872709,0.00002716801,0.0004825532,0.0000412257],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001617477,"about_ca_system_score_gemma":0.0004194853,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000443344,"about_ca_topic_score_gemma":0.0005047257,"domain_scores_codex":[0.9960687,0.0017526,0.0007922055,0.0006286429,0.0004816348,0.000276202],"domain_scores_gemma":[0.9950439,0.003853333,0.0002015022,0.0004924645,0.0001783108,0.0002305312],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0009010265,0.0009287634,0.9931831,0.00003390189,0.0001829798,0.00006466104,0.002656681,9.522947e-7,0.000006505231,0.00002449045,0.0008786099,0.001138274],"study_design_scores_gemma":[0.003828015,0.002080052,0.9910257,0.0001497316,0.0002627652,0.000005400261,0.001402027,0.00048335,0.00000557164,0.0004215143,0.0001826947,0.0001531731],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920419,0.0001462807,0.00002139507,0.002404426,0.0002249755,0.005072665,0.00001216112,0.00004521433,0.0000309942],"genre_scores_gemma":[0.9943104,0.000104754,0.00007044052,0.004390682,0.0001091752,0.0007300804,0.00004768166,0.0000276329,0.0002091515],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004342584,"threshold_uncertainty_score":0.7376884,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2005805496","doi":"10.1007/s40261-013-0053-5","title":"Effect of Implantation of Augment® Bone Graft on Serum Concentrations of Platelet-Derived Growth Factors: A Pharmacokinetic Study","year":2013,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Periodontal Regeneration and Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital","funders":"BioMimetic Therapeutics","keywords":"Augment; Medicine; Pharmacokinetics; Pharmacology; Platelet; Pharmacotherapy; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.03752778564131822,"gpt":0.3616140800555922,"spread":0.324086294414274,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003268521,0.000150751,0.0005003581,0.00009139621,0.00003541377,0.000006567964,0.00005119883,0.00007089726,0.0001014663],"category_scores_gemma":[0.0004776241,0.0001116041,0.0001272336,0.0001760378,0.0002083795,0.0001164911,0.00001589202,0.0001207102,0.0000161822],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003309313,"about_ca_system_score_gemma":0.00007610647,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002311712,"about_ca_topic_score_gemma":0.00001633284,"domain_scores_codex":[0.998071,0.0003734267,0.0009216872,0.0002114869,0.000309114,0.0001132719],"domain_scores_gemma":[0.9984863,0.0005127641,0.0004615847,0.000175732,0.0002031662,0.0001604667],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003131518,0.001064996,0.8164644,0.0002023674,0.0002397242,0.000003626762,0.001089122,0.00002096777,0.1772317,0.00008952527,0.0001716314,0.003108818],"study_design_scores_gemma":[0.004291684,0.002619527,0.5050555,0.00009242979,0.0001792448,0.000001437279,0.000116807,0.0003592024,0.4871887,0.00004392487,0.000002130349,0.00004949916],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978256,0.00002702783,0.0000167895,0.0002072991,0.0001434284,0.001618716,0.00003523019,0.00002245173,0.0001034918],"genre_scores_gemma":[0.9993922,0.00002768407,0.00009982392,0.00009363855,0.00003606442,0.00005639586,0.0002176175,0.00001224691,0.00006432777],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3114089,"threshold_uncertainty_score":0.4551083,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2891851132","doi":"10.1007/s40261-018-0694-5","title":"Regression and Genomic Analyses on the Association Between Dose-Normalized Mycophenolic Acid Exposure and Absolute Neutrophil Count in Steroid-Free, De Novo Kidney Transplant Recipients","year":2018,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; Vancouver General Hospital; University of Alberta","funders":"Vancouver Coastal Health Research Institute; University of British Columbia; F. Hoffmann-La Roche","keywords":"Medicine; Absolute neutrophil count; Mycophenolic acid; Neutropenia; Internal medicine; UGT2B7; Creatinine; Tacrolimus; Gastroenterology; Single-nucleotide polymorphism; Population; Immunology; Transplantation; Toxicity; Genotype; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.0895704304835811,"gpt":0.373520759183502,"spread":0.2839503286999209,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009795482,0.0001851485,0.000385754,0.0001072926,0.0001505293,0.0000432464,0.00009520259,0.0001785964,0.00001490599],"category_scores_gemma":[0.0004388841,0.0001177112,0.00007492751,0.0001800689,0.0001919014,0.0001136921,0.00002264048,0.0002964195,0.00001595949],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001444313,"about_ca_system_score_gemma":0.00009970128,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001094225,"about_ca_topic_score_gemma":0.00007060484,"domain_scores_codex":[0.9980948,0.0003818038,0.0006581224,0.0003373119,0.0002972533,0.0002306859],"domain_scores_gemma":[0.9984595,0.0006225061,0.0002770126,0.0002641306,0.00007555783,0.0003012955],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004185337,0.00006268407,0.993998,0.00005322433,0.0001522312,0.00001318564,0.0009555021,0.000002057539,0.003352004,0.00007404434,0.0001475519,0.0007709887],"study_design_scores_gemma":[0.005717173,0.0004086772,0.9891279,0.0008374712,0.0003312613,0.000009052234,0.00002970923,0.0001727,0.002345534,0.0007935722,0.0001173013,0.0001096445],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9943877,0.0001131066,0.00001966493,0.004625014,0.0001443485,0.0004214162,0.00008668664,0.00002746273,0.00017464],"genre_scores_gemma":[0.9954735,0.0008622851,0.0003867364,0.00262498,0.0002420045,0.00002213841,0.0001833855,0.00001791462,0.00018704],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005298639,"threshold_uncertainty_score":0.4800123,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1984348569","doi":"10.2165/11319610-000000000-00000","title":"Perioperative Use of Nonsteroidal Anti-Inflammatory Drugs","year":2009,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Ketorolac; Ketoprofen; Diclofenac; Perioperative; Ibuprofen; Nonsteroidal; Analgesic; Anesthesia; Pharmacology","retraction":null,"screen_n_in":null,"score":{"opus":0.04449040060894345,"gpt":0.3261087660218128,"spread":0.2816183654128694,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009543483,0.0001843903,0.0005269067,0.0001043759,0.00007288036,0.00002281252,0.00007937654,0.0001874377,0.00004257427],"category_scores_gemma":[0.001645494,0.0001544764,0.0002044797,0.0001781379,0.0004527003,0.0002908109,0.00002318257,0.0003848668,0.00008225179],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000305738,"about_ca_system_score_gemma":0.0002808792,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000009931942,"about_ca_topic_score_gemma":0.000002584845,"domain_scores_codex":[0.9979131,0.0002944963,0.0009211314,0.0003166662,0.0003350172,0.0002196521],"domain_scores_gemma":[0.9982134,0.0005516688,0.0002757631,0.0003643708,0.0002415635,0.0003532887],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004416678,0.0004005246,0.9122999,0.0002549359,0.0001062084,0.00008757555,0.004240441,0.00006603058,0.0464223,0.003098981,0.008074866,0.02450653],"study_design_scores_gemma":[0.002388534,0.0005550361,0.9426093,0.0003879647,0.0001163276,0.00001207277,0.0001345223,0.002522202,0.04781959,0.0003259085,0.002892234,0.0002363191],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969447,0.00004972481,0.00004198806,0.00139039,0.0004373875,0.0005244241,0.000005213971,0.00008044441,0.0005257021],"genre_scores_gemma":[0.9947219,0.00004367134,0.001700896,0.002513104,0.0004926415,0.000008087763,0.00003244684,0.00001709406,0.0004701605],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03030935,"threshold_uncertainty_score":0.6299366,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}